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Abstract 
 
Immunity declines with ageing resulting in an increase in incidence and 
severity of infections such as shingles.  We used the delayed type 
hypersensitivity response as a model for a memory T cell response to 
investigate differences in the response to VZV antigen administered into the 
skin between old and young individuals.  We found that there is a reduced 
clinical response, which is associated with a lack of T cell accumulation in the 
old subjects.  The earliest differences between the two groups include 
reduced activation of dermal endothelium and a reduced infiltration of CD11c+ 
dendritic cells in the skin of the old individuals after VZV antigen injection.  
This may reflect a defect in the ability of VZV specific T cells and / or innate 
immune cells resident in the skin to condition the cutaneous environment 
adequately to induce an effective adaptive immune response.  There is an 
increased level of Tregs in the normal skin of old individuals and these Tregs 
may suppress the activation of skin resident cells, thereby reducing early 
recruitment of memory T cells from the circulation as part of the immune 
response.  Without adequate recruitment and activation of a few VZV specific 
T cells, we propose there is failure to produce additional mediators needed to 
amplify the memory response.   
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Chapter 1.  Introduction 
 
1.1 The Skin Immune System 
 
The sixteenth century Italian physician Girolamo Mercuriale, author of what is 
considered to be the first scientific passage on skin diseases, mentions that 
there was general consensus among physicians of that time that the only 
functions of the skin were to provide a protective covering for the body and a 
receptacle for waste material (Sutton, R. L. 1986).  Hippocrates had 
previously highlighted the skin was needed to bind together individual body 
parts and Plato had likened it to a fisherman’s net  (Sutton, R. L. 1986). 
Today, the skin, a complex organ, is recognised to have multiple functions.  
Whilst providing a physical and chemical barrier to our external environment it 
also contains peripheral receptors and nerve endings allowing us to sense our 
surroundings.  Homeostatic functions help regulate body temperature and 
water loss.  The skin is able to utilise sunlight to synthesize Vitamin D3, yet 
contains melanin pigment to protect against sunlight induced DNA damage.  
In addition to the physical barrier, the skin houses elements of an elaborate 
immune system (Bos and Kapsenberg 1986) enabling us to tolerate benign 
foreign material yet raise an immune response to foreign pathogens.  The skin 
is made up of two main layers, the epidermis and the dermis.  These contain 
cells of the innate and adaptive immune system.  These cells may be resident 
within the skin, recruited from the circulation and some may recirculate 
through the skin (Table 1.1). 
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Table1.1: Innate and Adaptive Cells of the Skin Immune System (adapted from 
Bos 2004). 
 
 
1.2 T cell mediated immune responses 
1.2.1  Primary T cell response 
 
A primary T cell response is mediated by naïve T cells that, after leaving the 
thymus, circulate continuously via blood and lymph, repeatedly entering lymph 
nodes and other secondary lymphoid tissues (Gowans and Knight 1964; 
Picker and Butcher 1992).  Naïve T cells enter lymph nodes via high 
endothelial venules (HEVs) that constitutively express homing molecules to 
recruit lymphocytes.  These homing molecules mediate a process of T cell 
rolling, activation and arrest.  Essentially, there is a short-term tethering 
interaction between L-selectin on the naive T cell with peripheral node 
addressins (PNAd) on the HEV (Rosen 2004) that brings the CC-chemokine 
receptor 7 (CCR7) on the T cell into proximity with its ligand CC-chemokine 
ligand 21 (CCL21) on the HEV.  Activation of the integrin lymphocyte function-
associated antigen 1 (LFA-1) expressed on the T cell as a result of signalling 
induced by the binding of CCR7 to CCL21 results in firm engagement 
 RESIDENT RECRUITED RECIRCULATING 
INNATE Keratinocyte Monocytes Natural killer cells 
 Endothelial cells 
  Vascular 
  Lymphatic 
Granulocytes 
  Basophils 
  Eosinophils 
  Neutrophils 
Dendritic cells 
 Dendritic cells Mast cells  
 Mast cells   
 Tissue macrophages   
ADAPTIVE T lymphocytes T lymphocytes T lymphocytes 
  B lymphocytes  
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between LFA-1 and intercellular adhesion molecule 1 (ICAM-1) on the HEV 
causing T cell arrest (Shamri, Grabovsky et al. 2005).  These T cells 
subsequently transmigrate into the T cell zone of the lymph node. 
 
 
 
Figure 1.1 T cell migration through high endothelial vessels.   
T cells enter lymphoid tissue by crossing the walls of high endothelial vessels 
(HEVs).  There is initial binding between L-selectin (CD62L) on the T cell and 
peripheral node addressins (PNAd) on the HEV mediating a rolling interaction.  
Subsequent stimulation of CCR7 by CCL21 bound on the HEV luminal surface 
activates LFA-1 causing the T cell to bind firmly to ICAM-1 on the endothelial cell 
resulting in cell arrest. (Adapted from (Masopust and Schenkel 2013). 
 
A primary T cell response is initiated within secondary lymphoid tissue when a 
naïve CD4+ or CD8+ T cell encounters its specific foreign antigen peptide- 
major histocompatibility complex (MHC) on an activated antigen presenting 
cell (APC) (Germain and Stefanova 1999; Itano and Jenkins 2003).  Activated 
APCs that have captured pathogens at peripheral sites migrate to the regional 
lymph nodes and enter the T cell zone where they present antigen.  Activation 
of a naïve T cell involves the integration of three signals (Kapsenberg 2003).  
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The first is produced when the peptide-MHC on the APC binds to the T cell 
receptor (TCR) and co-receptor (either CD4 or CD8).  Engagement of co-
stimulatory molecules such as CD28 on the T cell with those on the APC 
provides a second signal, promoting survival and extensive proliferation of the 
antigen-specific T cell (Blattman, Antia et al. 2002).  The third signal provided 
by cytokines drive differentiation of the cells into one of a variety of effector 
subsets and directs migration.  With the exception of CD4+ follicular helper T 
cells (TFH)  that remain in the secondary lymphoid tissue and help orchestrate 
humoral responses by interacting with B lymphocytes (King, Tangye et al. 
2008), most other T cells leave to locate the site of active infection.   
 
During T cell activation in the secondary lymphoid tissue, T cells are 
effectively trapped within the T cell zone first to allow antigen sampling and 
then proliferation of activated cells (Shiow, Rosen et al. 2006).  However, as 
activation wanes, lymphocytes egress in response to a differential in 
concentration of sphingosine-1-phosphate (S1P), a signalling molecule 
abundantly expressed in blood and efferent lymph vessels (Cyster and 
Schwab 2012).  Activated T cells exiting the lymphoid tissue are also drawn to 
areas of inflammation by chemotaxis and may express homing molecules 
targeting them to non-lymphoid tissues e.g. skin homing T cells may express 
cutaneous lymphocyte antigen (CLA) which bind E-selectin expressed on 
activated cutaneous vascular endothelium (Berg, Yoshino et al. 1991); gut 
homing T lymphocytes express the integrin α4β7 and the receptor CC 
chemokine receptor 9 (CCR9) that binds to the intestinal mucosal addressin 
cell adhesion molecule-1 (MAdCAM-1) and the CC chemokine ligand 25 
(CCL25) on intestinal epithelial cells respectively (Wurbel, Malissen et al. 
2001; Salmi and Jalkanen 2005).  There is evidence that suggests expression 
of tissue homing molecules may reflect the site of T cell priming, for example 
T cells activated in skin draining lymph nodes display an enhanced capacity to 
migrate to inflamed skin while those activated in intestine associated lymphoid 
tissue become CCR9 and α4β7 expressing gut-tropic T cells (Campbell and 
Butcher 2002; Sigmundsdottir and Butcher 2008; Agace 2010).  However, the 
effect of this imprinting may be transient (Masopust, Choo et al. 2010) may be 
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influenced by trafficking through other distant lymph nodes (Liu, Fuhlbrigge et 
al. 2006) and may vary between CD4+ and CD8+ subsets (Gebhardt, Whitney 
et al. 2011).  
 
At the site of inflammation activated T cells carry out their effector functions. 
Activated CD8+ T cells all differentiate into cytotoxic T cells capable of killing 
infected target cells through the secretion of perforins, granzymes, granulysin 
and cytokines such as interferon-gamma (IFN-γ) and tumour necrosis factor-
alpha (TNF-α). In contrast CD4+ T cells differentiate into one of several 
effector subsets e.g. TH1, TH2, TH17 TFH, induced T regulatory cells (iTreg) 
(Mosmann, Cherwinski et al. 1986; Yamane and Paul 2012).  This is not a 
complete list of effector subsets and the number of subsets will presumably 
increase as effector T cells become better characterised allowing us to more 
accurately distinguish between them.  Although commitment to one of these 
lineages may begin during T cell activation in the secondary lymphoid tissue, 
it is recurrent exposure to antigen and polarising cytokines that determines 
further differentiation (Bajenoff, Wurtz et al. 2002).  IL-12 promotes the 
development of TH1 polarised cells that secrete IFN-γ while IL- 4 promotes the 
development of TH2 cells that typically secrete IL-4, IL-5 and IL13.  IL-6 and 
transforming growth factor-beta (TGF-β) promote development of TH17 cells 
that produce IL-17A, IL-17F, TNF-α, IL-21 and IL22 and depend upon IL-23 
for their development, survival and proliferation (Harrington, Hatton et al. 
2005; Park, Li et al. 2005).  TH17 are highly pro-inflammatory and help protect 
against extracellular bacteria and fungi. TH1 cells generally help clear 
intracellular pathogens while TH2 cells respond to parasitic pathogens. iTregs 
can be generated in the presence of TGF-β and are discussed in more detail 
below. 
  
After an adequate primary immune response to an infection has been 
mounted such that the effector T cells have removed the stimulus that 
originally recruited them, the majority of T cells undergo apoptosis.  However 
a small proportion of antigen experienced cells persist and provide a memory 
population for future encounters.   
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1.2.2 Memory T cell response  
 
Memory or recall responses occur more rapidly and are more pronounced 
than primary responses (Ahmed and Gray 1996).  This may in part due to the 
increased frequency of antigen specific cells, but it is also thought that 
memory T cells have reduced activation requirements, are able to respond to 
lower concentrations of antigen and require a shorter duration of antigenic 
stimulation (Berard and Tough 2002).  Memory cells may also proliferate more 
rapidly following TCR stimulation and display faster kinetics of cytokine 
secretion (Rogers, Dubey et al. 2000; Veiga-Fernandes, Walter et al. 2000; 
Berard and Tough 2002).  Memory cells also display altered patterns of 
adhesion molecule expression and migration (Masopust, Vezys et al. 2001). 
 
Circulating memory T cells have largely been divided into two functionally 
distinct subsets (Sallusto, Lenig et al. 1999; Sallusto, Geginat et al. 2004).  
Central memory T (TCM) cells are CD62L+CCR7+, typically migrate between 
blood and secondary lymphoid tissues akin to naïve T cells, are able to 
produce ample IL-2 and proliferate extensively in response to antigen 
stimulation and will eventually demonstrate effector functions.  In contrast 
effector memory T (TEM) cells are typically CD62L-CCR7-, circulate between 
blood and non-lymphoid tissues, have less proliferative capacity but rapidly 
secrete effector cytokines in response to antigen stimulation.   However, 
although CCR7 expression is a cardinal feature of TCM cells, CCR7 expression 
has also been found on memory cells within non-lymphoid tissues and 
appears to be required for emigration from these peripheral tissues 
(Campbell, Murphy et al. 2001; Bromley, Thomas et al. 2005; Debes, Arnold 
et al. 2005).  Several models have been proposed to reflect the relationship 
between these two memory subsets.  While some groups suggest that the two 
subsets are interdependent and that TCM cells may differentiate into TEM cells 
(Lanzavecchia and Sallusto 2000), or that TEM cells convert to TCM cells over 
time (Wherry, Teichgraber et al. 2003; Marzo, Klonowski et al. 2005), others 
suggest that they may represent two separate lineages (Baron, Bouneaud et 
al. 2003).   
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Recently, a tissue resident subset of TEM (TRM) cells that does not recirculate 
has been identified in various organs in animal studies (see Table 1.2) (Bevan 
2011).  Although most studies have shown these to be CD8+ T cells 
populations (Gebhardt, Wakim et al. 2009; Masopust, Choo et al. 2010; 
Wakim, Woodward-Davis et al. 2010; Gebhardt, Whitney et al. 2011; Jiang, 
Clark et al. 2012), a long lived CD4+ T cell population has been detected in 
mouse lung (Teijaro, Turner et al. 2011).  These TRM cells have, in some 
cases shown to provide superior protection compared to the circulating 
memory pool and as such may provide an important role in first line defence 
(Gebhardt, Wakim et al. 2009; Teijaro, Turner et al. 2011; Jiang, Clark et al. 
2012).  Heterogeneity within the TRM populations in different organs may 
reflect tissue specific signals, although several studies do highlight enhanced 
expression of CD69 and CD103 (Gebhardt, Wakim et al. 2009; Wakim, 
Woodward-Davis et al. 2010; Gebhardt, Whitney et al. 2011; Jiang, Clark et 
al. 2012).  CD103 is an integrin expressed at intermediate levels on naïve T 
cells, with expression down regulated upon activation.  Memory T cells 
maintain a low level of expression.  CD103 binds E-cadherin, an adhesion 
molecule found on epithelial cells (Cepek, Shaw et al. 1994).  It remains to be 
determined whether CD69 acts to prevent tissue egress as is seen with naïve 
T cells during activation in secondary lymphoid tissue (Shiow, Rosen et al. 
2006).  
 
There is evidence supporting the existence of such resident, non-recirculating 
memory T cells in human skin.  After treatment with low-dose alemtuzumab 
(anti-CD52) to treat T cell malignancies, some T cells persisted in the skin 
despite depletion of T cells from the blood (Clark, Watanabe et al. 2012).  
Xenografting of non-lesional human skin from a patient with psoriasis to 
severely immunocompromised mice results in active disease phenotype in the 
graft (Boyman, Hefti et al. 2004).  Furthermore intra-epidermal CD8+ T cells 
have shown to persist for years in fixed drug eruption lesions in the absence 
of repeat antigen challenge (Mizukawa, Yamazaki et al. 2008).  
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SUBSET PHENOTYPE LOCATION 
TCM CD62L+, CCR7+, 
CD69-, CD103- 
Lymph nodes, spleen (white pulp > red pulp), 
blood and bone marrow 
TEM CD62L-, CCR7-, 
CD69-, CD103- 
Spleen (red pulp > white pulp); fewer in lymph 
nodes, blood, lung, liver, intestinal tract, 
reproductive tract, kidney, adipose tissue and 
heart  
TRM CD62L-, CCR7-, 
CD69+, CD103+ 
CD8: epithelium of the skin, gut, and vagina; 
salivary glands and lung airways; brain and 
ganglia 
CD4: (?) lung parenchyma 
 
Table 1.2 Memory T cell subsets (Adapted from (Mueller, Gebhardt et al. 2013) 
 
Naïve, primed and memory T cell subsets can be distinguished by expression 
of CD45, the leukocyte common antigen (Trowbridge and Thomas 1994) that 
constitutes approximately 10% of the lymphocyte cell surface (Thomas 1998). 
CD45 is a tyrosine phosphatase that regulates signalling through antigen 
receptors and exists in multiple isoforms.  Naïve T cells express CD45RA, the 
highest molecular weight isoform, but this is rapidly lost during activation and 
the low molecular weight CD45RO isoform is up-regulated (Akbar, Terry et al. 
1988). CD45RO can be divided into CD45RB bright or dull cells and 
progressive differentiation of CD45RO cells is accompanied by a decline in 
CD45RB expression (Salmon, Pilling et al. 1994). Within the CD45RA and 
CD45RO populations, expression of the co-stimulatory molecules CD27 and 
CD28 can be used to identify more or less differentiated cells (Romero, 
Zippelius et al. 2007).   
However, studies have shown that some subsets of effector T cells can re-
express CD45RA and that these cells may be close to end-stage 
differentiation (Hamann, Kostense et al. 1999; Koch, Larbi et al. 2008).  Age 
and the presence of CMV infection have shown to contribute to the 
accumulation of these CD45RA re-expressing cells (Koch, Larbi et al. 2008; 
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Chidrawar, Khan et al. 2009; Libri, Azevedo et al. 2011).  Re-expression of 
CD45RA on memory cells may be driven by homeostatic cytokines in the 
absence of antigen (Geginat, Lanzavecchia et al. 2003; Dunne, Belaramani et 
al. 2005; Griffiths, Riddell et al. 2013).  The purpose of these CD45RA 
expressing effector T cells remains uncertain but it has been proposed that 
they represent a pool of short-lived potent effector cells (Henson, Riddell et al. 
2012). 
1.2.3 Delayed Type Hypersensitivity Response in the Skin  
 
A delayed type hypersensitivity (DTH) response is an in vivo manifestation of 
cell-mediated immunity (CMI) (Turk 1980; Landsteiner and Chase 1942).  It is 
a useful experimental system to study memory responses in the skin 
mediated by antigen-specific T cells in an immune individual.  Delivery of the 
antigen may be epicutaneous or via intradermal inoculation.  
 
The DTH skin test can be used clinically to determine infection with or prior 
exposure to a pathogen.  The Mantoux test (MT) is a classical DTH response 
whereby purified protein derivative (PPD) from Mycobacterium tuberculosis 
(M. tuberculosis) is injected intradermally.  A positive response in an 
immunocompetent individual indicates immunity acquired through natural 
infection or from the Bacille Calmette-Guerin (BCG) vaccine (Ahmed and 
Blose 1983).  DTH responses to common pathogens such as Candida 
albicans (C. albicans) can be used to give a general measure of cell-mediated 
immunity in potentially immunocompromised patients (Ahmed and Blose 
1983).  DTH responses to the varicella zoster virus (VZV) antigen skin test 
used in this study have been used previously to identify non-immune, 
susceptible young children during an outbreak of varicella in an institution 
(Kamiya, Ihara et al. 1977; Baba, Yabuuchi et al. 1978) and to assess the 
level of cell mediated immunity in immune adults to determine their risk of 
VZV reactivation and shingles (Okuno, Takao et al. 2013). 
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Clinically, positive skin DTH reactions give rise to an area of erythematous 
induration at the site of antigen challenge, typically on the forearm in humans 
and the ear or footpad in mice (Turk 1980).  Although some changes in the 
skin may be clinically evident just a few hours after antigen challenge, the 
clinical response typically peaks at 48 -72 hours in humans and at 24 hours in 
mice (Ahmed and Blose 1983)(Turk 1980).  After the peak, the clinical 
response resolves over the following 10 -14 days (Turk 1980). 
 
Histologically, the cutaneous DTH response to tuberculin PPD has been well 
characterised and is bi-phasic with an early non-specific response followed by 
a second specific response only seen in sensitized individuals (Boughton and 
Spector 1963; Platt, Grant et al. 1983).  The first phase consists of ‘danger 
signals’ thought to be provided by cells of the innate immune system in 
response to the antigen and mechanical trauma associated with its delivery 
(Matzinger 2002).  These signals are thought to facilitate the recruitment of 
leucocytes to mediate the specific adaptive response (Kupper and Fuhlbrigge 
2004).  The early infiltrate, within 6 hours after antigen injection, contains 
numerous neutrophils that decline in number thereafter, with a similar 
response seen in control subjects (Platt, Grant et al. 1983).  Perivascular 
mononuclear cells are evident 12 hours after antigen injection and both T cell 
and macrophage numbers increase rapidly peaking at 24-48 hours, with a 
predominance of T cells (Poulter, Seymour et al. 1982; Platt, Grant et al. 
1983; Chu, Field et al. 1992).  Only very few B lymphocytes are seen in the 
response (Poulter, Seymour et al. 1982; Platt, Grant et al. 1983; Gibbs, 
Ferguson et al. 1984).  CD4+ T cells outnumber CD8+ T cells at a ratio of 2:1 
throughout the response and although initially perivascular in distribution, after 
24 hours T cells can be seen more diffusely dispersed in the dermis, including 
around adnexal structures such as sweat glands, and in the epidermis 
(Poulter, Seymour et al. 1982; Platt, Grant et al. 1983; Gibbs, Ferguson et al. 
1984; Chu, Field et al. 1992).  The mechanism of this cellular infiltration 
remains poorly defined however innate responses are able to activate 
signalling pathways that regulate the expression of endothelial adhesion 
molecules, chemokines and cytokines.  These in turn are able to recruit both 
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non-specific leukocytes such as neutrophils and antigen-specific memory T 
cells (Kupper and Fuhlbrigge 2004).  However, since non-immune individuals 
do not raise a DTH response despite equal exposure to antigen and trauma to 
the skin, particular events must be induced to engage antigen-specific 
memory T cells in immune individuals.   
1.2.4 Initiation of a DTH response in skin 
 
A memory response, like a primary T cell response requires antigen to be 
presented to the memory T cell.  Dendritic cells (DCs), are professional APCs 
and have classically been defined by their ability to capture and process 
antigen in peripheral tissues where they reside and undergo maturation 
before migrating to secondary lymphoid organs where they activate naïve T 
cells (Banchereau and Steinman 1998).  The major resident DCs in human 
skin are Langerhans cells (LCs) that reside in the epidermis and dermal 
dendritic cells (dDCs) that reside in the dermis.  However, the relative 
contribution of these subsets in antigen presentation of intradermally injected 
antigen as part of a recall response in humans is not well defined.  It has been 
shown in mice models that both LCs and dDCs are able to take up ovalbumin 
protein delivered to the intradermal compartment and transport the antigen to 
the regional lymph nodes (Flacher, Tripp et al. 2010; Sparber, Tripp et al. 
2010).  It is proposed that the antigen enters the epidermal compartment by 
diffusion.  However ablation of LC’s does not diminish the subsequent 
cytotoxic response suggesting that the dDCs play a more crucial role 
(Flacher, Tripp et al. 2012).  Although most dDCs in normal skin are relatively 
immature, there is a small subgroup (~5%) expressing mature DC markers 
and this population may mediate rapid antigen presentation to local T cells 
(Zaba, Krueger et al. 2009).  In addition memory T cells are less stringent in 
their antigen-presenting requirements compared to naïve T cells (Croft, 
Bradley et al. 1994) such that skin resident cells e.g., macrophages (Geppert 
and Lipsky 1989) and keratinocytes (Black, Ardern-Jones et al. 2007) that are 
capable of presenting antigen may also play a prominent role in initiating a 
local recall response.   
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Furthermore, there is mounting evidence that memory immune responses can 
be initiated in the skin without the need for initial migration of DCs to the 
lymph nodes.  It has been demonstrated that normal human skin contains 
approximately 1x106 T cells per cm2 i.e. the skin surface of a normal adult 
would contain approximately 20 billion T cells, nearly twice the number seen 
in the entire blood volume (Clark, Chong et al. 2006).  More than 90% of CLA+ 
T cells were present in the skin.  These skin populating T cells were 
predominantly of a TH1 effector phenotype and demonstrated a diverse TCR 
repertoire (Clark, Chong et al. 2006). In support of this diverse TCR 
repertoire, studies have shown that primed T cells with skin homing molecules 
are distributed to all parts of the skin although the highest numbers are 
present at the site of initial pathogen exposure (Gebhardt, Wakim et al. 2009; 
Jiang, Clark et al. 2012).  Indeed studies in mice have confirmed that T cells 
can become activated, proliferate and carry out effector functions locally in 
non-lymphoid organs (Wakim, Waithman et al. 2008; Jiang, Clark et al. 2012).   
 
A locally initiated memory response in humans would be in keeping with the 
finding that changes are seen within a few hours in the skin after secondary 
antigen challenge yet it is estimated it would take 12 hours for antigen in the 
toe to travel to the inguinal lymph nodes (Mestas and Hughes 2004).  In 
addition, recall responses can occur in spite of compromised afferent 
lymphatics in patients with lymphoedema (Mallon, Powell et al. 1997).  
 
Therefore, there are three ways by which antigen-specific T cells appear in 
the skin.   Firstly, antigen-specific TRM and those TEM cells already present in 
the skin could become activated by antigen presented by one of several 
potential APCs.  Secondly, activation of dermal endothelium could recruit both 
antigen specific and non-specific circulating TEM cells into the skin.  Thirdly 
antigen laden dendritic cells could migrate to regional lymph nodes and 
present antigen to TCM cells, resulting in their proliferation and differentiation 
into antigen specific skin homing effector cells able to reinforce the early DTH 
response.  This concept is illustrated in Figure 1.2.     
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Figure 1.2 Dynamics of the memory T-cell recall response in peripheral tissue.  
 
 
Recall responses may incorporate 3 tiers of responding cells.  The first, TRM or TEM 
cells within the skin, may proliferate and exert effector functions after local antigen 
presentation.  Inflammation, leading to endothelial activation would allow recruitment 
of both specific and non-specific TEM cells that would display rapid effector functions 
upon activation.  Finally antigen-laden APCs migrating to regional lymph nodes 
would present antigen to TCM cells with subsequent proliferation and differentiation 
into skin homing effector cells. (Figure adapted from (Masopust and Schenkel 
2013)).   
1.2.5 T cell migration to the skin 
 
In order to recruit circulating T cells into the skin during a secondary memory 
immune response, both T cells and the activated endothelium of dermal post-
capillary venules must express corresponding adhesion molecules to allow T 
cells to adhere firmly to the endothelium before transmigrating into the skin 
(von Andrian and Mackay 2000).  The important contribution made by 
recruitment of circulating T cells has been shown in mouse studies where 
blocking chemokine or integrin mediated T cell recruitment results in a 
Skin 
Lymph  
node 
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diminished DTH response (Reiss, Proudfoot et al. 2001; Grabbe, Varga et al. 
2002).  
 
T cell migration consists of three stages, selectin-mediated rolling, 
chemokine-triggered activation and integrin-dependent arrest.  Transmigration 
into the tissue usually occurs in a paracellular manner but can be by the 
transcellular route mediated by CD31 (platelet endothelial cell adhesion 
molecule, PECAM-1), CD99 and junctional adhesion molecule (JAM) (Ley, 
Laudanna et al. 2007).  The adhesion molecules that mediate the process of 
migration are shown in table 1.3. 
 
 
Table 1.3 Adhesion molecules mediating T cell migration into inflamed skin  
 
 
1.2.5.1 Leucocyte rolling 
 
Leucocyte rolling is mediated by a weak, impermanent interaction between 
selectin molecules and their ligands.  Endothelial cells constitutively 
synthesise and store P-selectin, releasing it within minutes to the cell surface 
upon activation.  However, it is the expression of E-selectin in response to 
pro-inflammatory cytokines such as TNF-α, interleukin 1 (IL-1) (Bevilacqua 
1993) and IFN-Υ (Lee, Chung et al. 1995) that is considered to be important in 
 Lymphocyte adhesion 
molecule 
Endothelial adhesion 
molecule 
Rolling CLA 
PSGL-1 
E-selectin 
P-selectin 
Arrest LFA-1 
VLA-4 
ICAM-1 
VCAM-1 
Transmigration CD31 (PECAM-1) 
Junctional adhesion 
molecule; LFA-1, VLA-4 
CD31 (PECAM-1) 
Junctional adhesion 
molecule 
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recruiting memory cells into the skin during inflammation.  Memory T cells 
express P-selectin glycoprotein ligand 1 (PSGL-1) to allow entry into to 
peripheral sites of inflammation.  Skin homing memory T cells also express 
CLA, a modified PSGL-1 molecule that facilitates binding to E-selectin (Berg, 
Yoshino et al. 1991; Fuhlbrigge, Kieffer et al. 1997).  The rolling motion that 
results from these interactions is slower than that of free-flowing cells and 
allows sampling of the endothelial surface for activating molecules such as 
chemokines. 
 
1.2.5.2 Leucocyte activation and arrest 
  
To stop rolling, T cells must engage additional receptors of the integrin family.  
Memory T cells express the integrins LFA-1 and very late antigen-4 (VLA-1), 
which bind ICAM-1 and VCAM-4 (vascular cell adhesion molecule-4) 
expressed on activated endothelium respectively (von Andrian and Mackay 
2000).  However, to mediate cell arrest, these integrins need to receive 
activating signals.  These intracellular activating signals occur in response to 
the T cell binding chemokines expressed on the endothelial surface.  
Activated integrins undergo a conformational change that results in a higher 
binding affinity with their ligands decreasing the rate of ligand dissociation 
(Ley, Laudanna et al. 2007).  Chemokines are secreted polypeptides that may 
be synthesized and/or presented by activated endothelial cells on their luminal 
surface or in the extracellular matrix to trigger intravascular cell arrest or direct 
the migration of T cells (Campbell, Hedrick et al. 1998).  Several chemokine 
receptors e.g. CCR4, CCR10, CCR6 and CCR8 may play a role in recruiting T 
cells into the skin though CCR4 appears to play a central role (Campbell, 
Haraldsen et al. 1999; Fitzhugh, Naik et al. 2000; Reiss, Proudfoot et al. 2001; 
Campbell, O'Connell et al. 2007; Islam, Chang et al. 2011).  CLA+ T cells 
typically co-express CCR4 in the skin and to a lesser degree in the circulation 
(Clark, Chong et al. 2006).  The CCR4 ligand, thymus and activation 
regulated chemokine (TARC) is constitutively expressed at low levels in the 
skin and expression can be up-regulated in cutaneous inflammation (Saeki 
and Tamaki 2006).  
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1.2.6 T cell proliferation during a cutaneous DTH response 
 
During a DTH response in the skin there is an initial accumulation of T cells 
followed by a decline in T cell numbers (Poulter, Seymour et al. 1982).  This 
accumulation may in part result from proliferation of antigen-specific T cells in 
the skin, which are either resident or have been recruited from the circulation.  
It has been shown in mice during a memory CD8+ T cell response to HSV, 
that tissue-resident antigen-specific T cells can undergo stimulation and 
proliferation in response to local infection in the dorsal root ganglia (Wakim, 
Waithman et al. 2008).  The same group has also shown that during the 
memory response, both antigen specific and non-specific CD8+ T cells are 
recruited to the dorsal root ganglia and that there is subsequent local 
expansion of the antigen-specific T cells through proliferation rather than 
simply preferential accumulation and retention of circulating antigen-specific T 
cells (Wakim, Gebhardt et al. 2008).  Published work from our group also 
suggests that there is in situ proliferation of antigen-specific T cells during the 
Mantoux response in humans although we were unable to distinguish if this 
was proliferation of resident or recruited TEM cells (Vukmanovic-Stejic, Agius 
et al. 2008).  
1.2.7 Regulatory T cells and their role in a cutaneous DTH response 
 
Regulatory T cells (Tregs) are a subset of T cells that exert a suppressive or 
regulatory role, important in immunological self-tolerance and resolution of 
immune responses to foreign antigens (Sakaguchi 2004).  Tregs were 
identified within a subset of CD25+ T cells that make up 5-10% of peripheral 
CD4+ T cells and less than 1% of peripheral CD8+ T cells in naive mice and 
humans (Sakaguchi, Sakaguchi et al. 1995; Sakaguchi 2004).  The 
importance of Tregs was demonstrated in experiments where depletion of this 
CD25+ subset from mice was sufficient to activate self-reactive T cells and 
elicit autoimmune disease (Sakaguchi, Sakaguchi et al. 1995).  Foxp3 is a 
transcription factor expressed by Tregs and is required for Treg development 
(Ohkura, Kitagawa et al. 2013).  Mutations of human Foxp3 result in impaired 
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Treg function and immune dysregulation polyendocrinopathy enteropathy X-
linked syndrome (IPEX) that manifests with severe autoimmune diseases, 
inflammatory bowel disease and allergy (Bennett, Christie et al. 2001; 
Bacchetta, Passerini et al. 2006).  Mice with mutations in the Foxp3 gene 
develop fatal lymphoproliferative disorder due to a deficiency of Tregs 
(Brunkow, Jeffery et al. 2001; Fontenot, Gavin et al. 2003).  Foxp3 had been 
proposed as a Treg lineage specific factor (Fontenot, Rasmussen et al. 2005) 
but it was later shown that activated conventional CD4+ T cells may 
temporarily up-regulate expression of Foxp3 without acquisition of Treg 
function (Gavin, Torgerson et al. 2006; Allan, Crome et al. 2007; Wang, Ioan-
Facsinay et al. 2007).  
 
Naturally occurring Tregs (nTregs) are produced by the thymus (Itoh, 
Takahashi et al. 1999).  Naïve nTregs are CD45RA+ (Valmori, Merlo et al. 
2005) and are thought to circulate in a manner akin to conventional naïve T 
cells, being activated in regional lymph nodes (Sakaguchi, Yamaguchi et al. 
2008).  Like conventional T cells, activated nTregs give rise to a CD45RO+ 
memory nTreg population (Miyara, Yoshioka et al. 2009; Booth, McQuaid et 
al. 2010).  nTregs generated in the thymus are widely thought to be reactive 
for self-antigens, having escaped deletion and instead acquired suppressive 
function (Jordan, Boesteanu et al. 2001; Hsieh, Lee et al. 2012).  However, 
Treg populations can also be generated in the periphery from conventional 
CD4+ T cells during both inflammatory and non-inflammatory conditions and 
these are referred to as adaptive or induced Tregs (iTregs) (Bilate and Lafaille 
2012). In keeping with this it has been shown that Tregs maintain a highly 
diverse TCR repertoire that include most of the TCRs dominantly expressed 
by naïve T cells, and that the frequency of TCRs with high affinity for self-
versus non-self antigens is similar within the CD4+Foxp3+ Treg and 
CD4+Foxp3- naïve T cell populations (Pacholczyk, Kern et al. 2007).   
 
Tregs can be identified by their expression of Foxp3 although as mentioned 
above Foxp3 is also transiently expressed on activated T cells.   However, a 
Treg-specific demethylated region (TSDR) at the foxp3 locus in nTregs, 
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relates to stability of Foxp3 expression (Floess, Freyer et al. 2007) and in 
combination with Foxp3 identifies cells committed to Treg cell lineage 
(Ohkura, Hamaguchi et al. 2012).  However, the intracellular location of these 
markers limits their use to isolate Tregs for further analysis.  
 
Surface markers used to identify Tregs include: high levels of CD25, cytotoxic 
T-lymphocytes-associated protein 4 (CTLA-4), an inhibitory receptor which 
competes with CD28 for B7 ligands expressed on activated DCs, and 
glucocorticoid-induced TNFR-related protein (GITR), a member of the TNF 
receptor superfamily.  Both CTLA-4 and GITR are constitutively expressed on 
nTregs whereas expression of these receptors is only up-regulated on 
conventional T cells after activation.  CD127, the alpha chain of the IL-7 
receptor, is often used in conjunction with CD25 to distinguish between CD25+ 
activated conventional T cells and Tregs since expression of CD127 is high 
on activated conventional T cells and low on Tregs (Liu, Putnam et al. 2006; 
Seddiki, Santner-Nanan et al. 2006).  CD39, an ectonucleotidase found on 
nTregs responsible for cleaving adenosine triphosphate (ATP) to adenosine 
monophosphate (AMP) (Borsellino, Kleinewietfeld et al. 2007; Deaglio, Dwyer 
et al. 2007) has also been used in combination with CD25+ to more accurately 
isolate Treg populations (Mandapathil, Lang et al. 2009; Schuler, 
Harasymczuk et al. 2011) although CD39 is also expressed on multiple other 
activated immune cells.  Expression of Helios, an Ikaros transcription family 
member was thought to be limited to nTregs (Thornton, Korty et al. 2010), 
however others report that Helios may be expressed on in vitro generated 
iTregs (Verhagen and Wraith 2010) as well as activated CD4+ T cells 
(Akimova, Beier et al. 2011).  Similarly neuropilin 1 (Nrp 1), a receptor for 
members of the vascular endothelial growth factor (Soker, Takashima et al. 
1998) and semaphorin family (Kolodkin, Levengood et al. 1997) has been 
used to distinguish Tregs (high expression) from activated T cells (low 
expression) (Bruder, Probst-Kepper et al. 2004) and had been proposed as a 
marker to help distinguish nTregs from in vivo generated iTregs (Yadav, 
Louvet et al. 2012).  However, while iTregs generated in tolerogenic 
environments are largely Nrp-1lo, Nrp-1 is expressed on iTregs generated in 
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inflammatory conditions (Weiss, Bilate et al. 2012).  The lack of a specific 
marker to distinguish between Tregs and activated T cells means a 
combination of markers is often used in functional studies and differences in 
the markers used may give rise to some discrepancies in data generated by 
different groups.  The lack of a marker to differentiate between nTregs and 
iTregs means it is not currently possible to determine if Tregs are definitively 
of nTreg or iTreg origin in vivo in humans. 
 
Although Tregs are activated in an antigen specific manner, they are able to 
carry out their effector functions in an antigen non-specific manner 
(Takahashi, Kuniyasu et al. 1998).  Tregs can suppress various stages of 
immune responses by targeting effector T cells as well as APCs (Vignali, 
Collison et al. 2008) using both contact dependent and contact independent 
mechanisms, although the exact mechanisms of suppression remain unclear. 
Contact dependent mechanisms include physical interference preventing 
antigen-specific naïve T cells from accessing APCs as a result of preferential 
binding of Tregs to APCs compared to naïve T cells (Onishi, Fehervari et al. 
2008; Yokosuka, Kobayashi et al. 2010); use of the cytotoxic molecules 
granzyme and perforin to induce T cell or DC apoptosis (Cao, Cai et al. 2007; 
Boissonnas, Scholer-Dahirel et al. 2010); upregulation of the tryptophan 
catabolising enzyme indolamin 2,3-dioxygenase (IDO) on DCs which has 
immunoregulatory effects and can hinder the activation of T cells (Fallarino, 
Grohmann et al. 2003); expression of CD39, a nucleoside triphosphate 
diphosphohyrodolase-1 and CD73, an ecto-5’-nucleotidase (Kobie, Shah et al. 
2006; Deaglio, Dwyer et al. 2007) which help generate adenosine, a potent 
inhibitor of T cell responses (Huang, Apasov et al. 1997).  Contact 
independent mechanisms include IL-2 sequestration from the environment 
ahead of conventional antigen-specific T cells (Thornton and Shevach 1998; 
O'Gorman, Dooms et al. 2009; Busse, de la Rosa et al. 2010) and release of 
immune suppressive cytokines such as TGF-β and IL-10 (Fahlen, Read et al. 
2005; Kearley, Barker et al. 2005; Strauss, Bergmann et al. 2007; Rubtsov, 
Rasmussen et al. 2008).  The mechanisms used are likely to vary according 
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to whether Tregs are acting to provide immune tolerance or immune 
regulation (Yamaguchi, Wing et al. 2011). 
 
Tregs make up approximately 5-15% of the T cell population resident in 
normal skin (Clark and Kupper 2007; Agius, Lacy et al. 2009) and the vast 
majority of these Tregs express CD45RO+ corresponding to a memory Treg 
population (Booth, McQuaid et al. 2010).  This significant presence of memory 
Tregs in the skin is not surprising given that the skin is the interface with the 
external environment and must mediate both tolerance to harmless and self 
antigens in the absence of inflammation and mount immune responses to 
invading pathogens.  Circulating Tregs express high levels of skin homing 
molecules, with uniform expression of CCR4, 80% expressing CLA and 73% 
expressing CCR6 (Hirahara, Liu et al. 2006).  This expression of skin homing 
molecules on circulating Tregs is more pronounced than on circulating CD4+ 
non-Treg T cells.  The importance of Tregs being able to access the skin even 
in the absence of inflammation is highlighted in a study where loss of 
fucosyltransferase VII enzyme which leads to generation of part of the CLA 
molecule, dramatically reduced Treg accumulation in the skin, and resulted in 
onset of severe cutaneous inflammation (Dudda, Perdue et al. 2008).  In the 
absence of inflammation, it has been shown that LCs induce the activation 
and proliferation of skin resident Tregs and this is thought to play a role in the 
maintenance of tolerance in normal skin (Seneschal, Clark et al. 2012).   
During an in vivo recall response to PPD in human skin our group has shown 
that Tregs proliferate in situ and accumulate with kinetics very similar to those 
of conventional memory CD4+ T cells (Vukmanovic-Stejic, Agius et al. 2008).  
This fine balance between theses two populations and their lifelong 
maintenance is presumably crucial in regulating the intensity and resolution of 
memory responses (Akbar, Vukmanovic-Stejic et al. 2007). 
 
1.3 Cellular innate immune system in the skin 
 
Cells of the innate immune system also reside in or are recruited into the skin 
and compose the early innate immune response. These include 
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monocytes/macropahges, polymorphonuclear leukocytes, dendritic cells and 
NK cells (Goodarzi, Trowbridge et al. 2007).  These cells have pattern 
recognition receptors (PRRs) that recognise pathogen-associated molecular 
patterns (PAMPS), molecules typical of a microbes and damage associated 
molecular patterns (DAMPs), typically host-derived intracellular molecules 
(Matzinger 2002; Medzhitov and Janeway 2002; Kono and Rock 2008).  
PRRs mediate directed phagocytosis, activate inflammatory signalling 
pathways, induce cell death and activate complement or coagulation 
cascades (Janeway and Medzhitov 2002; Clark and Kupper 2005).  Toll-like 
receptors (TLR) were the first PRRs to be identified and have been well 
characterised in humans.  TLRs are expressed on both innate immune cells 
and on other cells such epithelial cells, endothelial cells and fibroblasts (Clark 
and Kupper 2005).  Where the innate immune response cannot contain an 
infection, it instructs and directs an adaptive immune response.  
1.3.1 Macrophages 	  
Macrophages, derived from circulating monocytes, are a tissue resident 
population (van Furth and Cohn 1968).  They use PRRs to recognise and 
subsequently phagocytose and eliminate pathogens (Aderem and Underhill 
1999).  In response to pathogen binding macrophages release pro-
inflammatory cytokines such as IL-1β, IL-6, IL-12, TNF-α and the chemokine 
CXCL8 to induce a state of inflammation (Janeway 2012).  Such inflammation 
activates local endothelium to express adhesion molecules that promote the 
recruitment of other effector leucocytes.  Activated macrophages are also able 
to process and present antigen via MHC class II molecules to primed effector 
CD4+ T cells (Underhill, Bassetti et al. 1999).  Macrophage activation may be 
influenced by the environmental cytokine milieu during an immune response.  
IFN-γ primes macrophages to undergo classical activation and develop a 
harsh pro-inflammatory response while IL-4 and IL-13 promote alternative 
activation of macrophages (Martinez 2011).  Alternatively activated 
macrophages are associated with the synthesis of anti-inflammatory and 
tissue repair factors (Van Dyken and Locksley 2013).   
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1.3.2 Dendritic Cells  
 
1.3.2.1 Langerhans Cells (LCs) 	  	  
Langerhans cells reside in the suprabasal layers of epidermis. They are 
thought to be continuously replaced from a resident precursor pool throughout 
life under steady-state conditions but during inflammation when LCs migrate 
out of the skin in large numbers, LCs are most likely repopulated by blood 
borne mononcytes (Merad, Manz et al. 2002; Ginhoux, Tacke et al. 2006).  
Classically, LCs were thought to perform an immunostimulatory role by 
capturing and processing cutaneous antigens, migrating to draining lymph 
nodes and presenting antigen to activate T cells (Banchereau and Steinman 
1998).  However, recent observations suggest that while they generate T cell 
effector responses during skin infection, in the steady state LCs mediate 
tolerance presumably to commensal flora by inducing proliferation of skin 
resident Tregs (Seneschal, Clark et al. 2012). 
 
1.3.2.2 Dermal dendritic cells (dDC) 	  
These are several DC subsets resident in the dermis of human skin but there 
is no single or specific marker for them and they are currently best identified 
by the integrin CD11c (Zaba, Fuentes-Duculan et al. 2007).  The major DC 
population in the dermis of the skin is blood dendritic cell antigen 1 positive 
(BDCA-1+) (Zaba, Krueger et al. 2009) also known as CD1c.  Members of the 
CD1 family are able to present lipid antigens such as those from M. 
tuberculosis (Cohen, Garg et al. 2009).  In the steady state these BDCA-1+ 
DCs are relatively immature with moderate T-cell stimulatory ability but this is 
greatly enhanced with DC maturing stimuli (Zaba, Fuentes-Duculan et al. 
2007).  A proportion of these BDCA-1+ DCs also express CD1a (Zaba, 
Krueger et al. 2009) and CCR7 and exhibit a chemotactic response to the 
lymph node chemokine CCL19, compatible with a migratory role to draining 
lymph nodes for antigen presentation (Angel, George et al. 2006). Other 
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minor resident dermal dendritic cell populations have also been identified.  
BDCA-3+ DCs constitute approximately 10% of all CD11c+ DCs (Zaba, 
Krueger et al. 2009) and are able to cross present antigen to CD8+ T cells in 
vitro (Haniffa, Shin et al. 2012).  BDCA-1+ and BDCA-3+ dDCs may be derived 
from their circulating counterparts (Autissier, Soulas et al. 2010). A less-well 
defined monocyte or macrophage-like CD14+ population which may arise from 
monocytes is also present in the dermis of normal skin (Angel, Lala et al. 
2007; Collin, McGovern et al. 2013).   
 
During cutaneous inflammation, additional ‘inflammatory’ dermal dendritic 
cells appear.  These include TNF and inducible NOS producing DCs (Tip-
DCs) found in psoriasis (Lowes, Chamian et al. 2005) and inflammatory 
dendritic epidermal cells (IDECs) found in atopic dermatitis (Guttman-Yassky, 
Lowes et al. 2007).  It is unclear whether these are derived from circulating 
DC precursors, monocytes or resident DCs (Zaba, Krueger et al. 2009) and 
whether they have the ability to migrate to lymph nodes (Collin, McGovern et 
al. 2013). 
1.3.2.3 Plasmacytoid dendritic cells  	  
Plasmacytoid dendritic cells (pDCs) are characterised by their ability to rapidly 
make vast quantities of type 1 interferon during viral infections.  They make 
200-1000 times more type I interferon than any other blood cell type in 
response to viral PAMPs binding to their PRRs (TLR7 and TLR9) (Siegal, 
Kadowaki et al. 1999; Gilliet, Cao et al. 2008).  Although pDCs are able to 
present antigen to T cells, their primary role is thought to be in antiviral 
defence.  pDCs circulate in the blood, representing 0.5% of peripheral blood 
mononuclear cells in humans (Auffray, Sieweke et al. 2009).  They are rarely 
present in normal skin of healthy adults (Zaba, Krueger et al. 2009) (Ebner, 
Ehammer et al. 2004; Nestle, Conrad et al. 2005) but are thought to play a 
role in the development of skin lesions in patients with psoriasis (Nestle, 
Conrad et al. 2005) .  They lack the surface marker CD11c but exclusively 
express BDCA-2 (Dzionek, Fuchs et al. 2000). 
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1.3.3 Neutrophils  	  
Unlike macrophages and dendritic cells, neutrophils are not present in healthy 
tissue but are typically the first leukocyte population to be recruited during 
acute inflammation accumulating in large numbers (Peters, Egen et al. 2008; 
Basran, Jabeen et al. 2013).  Neutrophils make up 50-70% of circulating 
leukocytes (Mestas and Hughes 2004).  They are very short lived with a half-
life of 8-12 hours in the circulation (Dancey, Deubelbeiss et al. 1976) although 
this is increased several fold during inflammation in response to cytokines, 
growth factors and bacterial products (Colotta, Re et al. 1992).  During 
maturation, granules form inside the neutrophil and contain pro-inflammatory 
proteins.  Neutrophils are able to mediate both intracellular and extracellular 
elimination of pathogens e.g., they can release the contents of their granules 
either into phagosomes or into the extracellular milieu (Kolaczkowska and 
Kubes 2013).  
 
Murine studies have identified distinct neutrophil subsets that vary in their 
cytokine and chemokine production, macrophage activation and TLR 
expression (Tsuda, Takahashi et al. 2004) and in this way neutrophils may 
influence innate immune responses.  However it is not clear if these subsets, 
broadly divided into pro-inflammatory and anti-inflammatory neutrophils, arise 
as a consequence of inflammation or whether they truly represent distinct 
lineages. Neutrophils may promote adaptive immune responses by providing 
an early source of IFN-γ in infection (Yin and Ferguson 2009) or by acting as 
antigen-presenting cells (Duffy, Perrin et al. 2012).  Other work however, has 
highlighted the ability of neutrophils to suppress T cell function (Pillay, Kamp 
et al. 2012).   
 
1.4 Cytokines and chemokines and their role in immune responses in 
the skin  
 
Cytokines are small proteins that are produced by various cells in body and 
bind to specific receptors. They may act in an autocrine, paracrine and in 
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some circumstances, endocrine manner.  Chemokines are chemoattractant 
cytokines that induce chemotaxis in nearby responsive cells promoting their 
recruitment along a gradient of increasing concentration towards the source 
cell.  Chemokines are structurally divided into C, CC, CXC, CX3C chemokines 
bases on the distribution of cysteine motifs involved in the formation of 
disulphide bonds and have crucial roles in both homeostasis and disease 
states (Blanchet, Langer et al. 2012).   
 
TLRs are expressed by antigen presenting cells such as macrophages and 
dendritic cells but are also present on a variety of other cell types in the skin 
such as keratinocytes, fibroblasts and endothelial cells (Miller and Modlin 
2007).  TLRs initiate downstream signalling events that culminate in the 
production of inflammatory cytokines, production of antiviral type 1 interferons, 
chemokines and antimicrobial peptides (Kawai and Akira 2011).  Pro-
inflammatory cytokines secreted early in the immune response predominantly 
by macrophages and dendritic cells include IL-1, TNF-α, IL-6 and IL-12 (Miller 
and Modlin 2007).  TNF-α and IL-1 activate vascular endothelium to express 
adhesion molecules such as E-selectin, ICAM-1 and VCAM-1 (Bevilacqua, 
Pober et al. 1987; Bertini, Sironi et al. 1992; Groves, Allen et al. 1995) 
augmenting recruitment of neutrophils, monocytes (Ming, Bersani et al. 1987) 
and skin-homing T cells (Picker, Kishimoto et al. 1991).  IL-12 activates 
recruited NK cells to secrete large amounts of IFN-γ and both IL-12 and IFN-γ 
promote differentiation of CD4+ T cells to into pro-inflammatory TH1 cells 
(Trinchieri 1995).  IFN-γ is also produced by activated TH1 cells and activates 
macrophages to increase their antimicrobial activity and expression of MHC-II 
molecules (Basham and Merigan 1983; Nathan, Murray et al. 1983). 
 
In response to stimulation by cytokines such as IL-1, TNF-α and IFN-γ, other 
resident cells such as keratinocytes, dermal fibroblasts and endothelial cells 
as well as inflammatory cells produce various chemokines (Elbe, Foster et al. 
1996) which play a role in leukocyte recruitment.  Members of the CXC 
chemokine subfamily such as CXCL8/IL-8 are important for neutrophil 
recruitment and are significantly up regulated in psoriatic skin accounting for 
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the characteristic intra-epidermal pustules that are seen (Hautz, Wolfram et al. 
2012).  Members of the CC chemokine subfamily such as CCL2/MCP-1 and 
CCL5/RANTES are thought to predominantly attract monocytes (Schroder 
1995).  Both CXC and CC chemokines attract T cells (O'Garra, McEvoy et al. 
1998; Rossi and Zlotnik 2000).  Therefore, PRRs activate signalling that 
induces an innate response and shapes the adaptive immune response 
according to the stimulating pathogen. 
 
1.5 Impact of ageing on health 
 
Over the last 30 years the number of centenarians in the UK has increased 
five fold from 2,500 in 1980 to 12,640 in 2010 (ONSa 2011) and in 2011 it was 
estimated that just under 1% of the total population was aged 90 and over 
(ONSb 2013).  However, ageing is accompanied by a decline in effective 
immune responses resulting in increased susceptibility to infections and 
reduced responses to vaccines.  
 
There is an increase prevalence of infections such as urinary tract infections, 
lower respiratory tract infections, skin and soft tissue infections, intra-
abdominal infections, infective endocarditis, bacterial meningitis, tuberculosis 
and herpes zoster in the elderly, as well as increased morbidity and mortality 
from these infections (Yoshikawa 2000). Paradoxically ageing is also 
associated with a state of chronic low-level inflammation with an increase in 
circulating levels of pro-inflammatory cytokines such as TNF-α, IL-6 and IL-1β 
referred to as inflamm-ageing (Fagiolo, Cossarizza et al. 1993; Franceschi, 
Capri et al. 2007).  Inflamm-ageing is thought to contribute to a variety of age-
related pathologies such as atherosclerosis (Vasto, Candore et al. 2007), type 
II diabetes, osteoporosis and cognitive decline (Cevenini, Monti et al. 2013). 
 
Vaccines are one way to boost immune responses and in the US four are 
recommended for persons 60 years and over (CDC - 2013).  However the 
response of old people to these vaccines is less robust than in younger 
groups due to age-related changes in the immune system (Weinberger, 
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Herndler-Brandstetter et al. 2008).  Vaccine efficacy in the elderly to protect 
against influenza has been estimated to be between 17-53% compared to 70-
90% in young adults (Goodwin, Viboud et al. 2006).  The efficacy of the zoster 
vaccine to prevent herpes zoster also declines with age (64% in those aged 
60-69 years, 38% in those >80 years) (Levin 2012).      
 
Given the change in population demographic it is becoming increasingly 
important to understand age-related immune defects if we are to match the 
increased life expectancy with quality of life. 
1.5.1 Effect of ageing on T cells 
 
T cells develop in the thymus but there is a steady loss of functional thymic 
tissue with age that proceeds rapidly before middle age and relatively slowly 
thereafter and is almost complete by the sixth decade (Steinmann, Klaus et al. 
1985; Aspinall and Andrew 2000).  Despite this, the size of the T cell pool is 
maintained during adult life by turnover of pre-existing populations in 
response to homeostatic mechanisms (Surh and Sprent 2008).  However, the 
composition switches from one of mostly naïve T cells in young individuals to 
one of predominantly memory T cells in later life, with an accumulation of end-
differentiated effector cells particularly within the CD8+ T cell subset (Goronzy 
and Weyand 2012).  This increase in memory T cells may represent the 
cumulative effect of antigen encounters as well as homeostatic expansion.  
 
However, one potential consequence of repeated cell division is shortening of 
telomeres in T cells with ageing (Rufer, Brummendorf et al. 1999; Fletcher, 
Vukmanovic-Stejic et al. 2005; Akbar and Vukmanovic-Stejic 2007).  
Telomeres are repeating hexameric sequences of DNA that protect the ends 
of chromosomes (Blackburn 2005).  However, each cell division results in loss 
of approximately 50 base pairs of telomeric DNA due to the inability of DNA 
polymerase to fully replicate to the ends of the chromosomes during DNA 
replication (Harley, Futcher et al. 1990).  The rate of telomere loss can be 
reduced by the enzyme telomerase that synthesises hexameric repeats 
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restoring telomere length (Blackburn 2005).  However, although this enzyme 
is initially up regulated upon T cell activation, with repeated stimulation T cells 
lose the ability to induce telomerase (Maini, Soares et al. 1999; Plunkett, 
Soares et al. 2001; Valenzuela and Effros 2002). At a critical minimal 
telomere length, the cell enters cell cycle arrest and a state of replicative 
senescence (Weng, Levine et al. 1995; Effros and Pawelec 1997).  CD28 co-
stimulation plays a key role in up-regulating telomerase activity during 
activation and a decline in telomerase activity parallels the loss of CD28 
expression (Weng, Levine et al. 1996; Valenzuela and Effros 2002), also seen 
in ageing.   
 
Ageing is associated with changes in expression of surface molecules on T 
lymphocytes and the accumulation of CD28- memory T cells, predominantly 
within the CD8+ T cell subset, is a consistent age-associated change in 
humans (Fagnoni, Vescovini et al. 1996).  CD28 is a co-stimulatory molecule 
that interacts with CD80 and/or CD86 expressed on activated APCs and plays 
a role in T cell activation, proliferation and survival (Riley and June 2005).  
CD28- T cells show reduced proliferation in response to TCR stimulation 
(Azuma, Phillips et al. 1993).  However CD28- T cells do possess enhanced 
cytotoxic capacities (Azuma, Phillips et al. 1993), consistent with their 
predominant effector-memory status. 
 
Elderly individuals also have expanded end-differentiated effector T cells 
populations that re-express CD45RA, particularly within CD8+ T cell subset 
(Akbar and Fletcher 2005).  These end-differentiated cells are usually 
oligoclonal indicative of chronic antigen stimulation and can be seen in people 
with chronic cytomegalovirus (CMV) infection (Chidrawar, Khan et al. 2009). 
These populations may also in part be expanded in response to homeostatic 
cytokine induced proliferation (Chiu, Fann et al. 2006; Griffiths, Riddell et al. 
2013).  Such oligoclonal expansions of memory lymphocytes are proposed to 
be detrimental in ageing as they take up ‘immunological space’ depriving 
other T cells of resources such as cytokines and surface ligands, constraining 
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adaptive immune response to other existing or new antigens (Khan, Hislop et 
al. 2004).   
 
Age-related functional changes are also evident in the naïve T cell 
compartments and naïve CD4+ T cells from aged humans show reduced in 
vitro responsiveness to TCR and co-receptor stimulation and altered cytokine 
profile compared to naïve CD4+ T cells from young individuals (Thompson, 
Wekstein et al. 1984; Linton, Haynes et al. 1996; Weng 2006) 
1.5.2 Effect of ageing on innate immunity 
 
Previous studies have shown that ageing appears to affect all the major cell 
types involved in the innate immune response.  Most aspects of neutrophil 
function including chemotaxis, phagocytosis and generation of superoxide in 
response to stimulation by host and pathogen factors are decreased in the 
elderly (Panda, Arjona et al. 2009). In addition neutrophils are less able to 
respond to survival signals such as GM-CSF provided at sites of inflammation 
(Fortin, Larbi et al. 2007), reducing their ability to resolve infections.  
A number of monocyte/macrophage functions decline with ageing.  In 
particular monocytes from old individuals show an age-associated defect in 
TLR-induced production of TNF-α and IL-6, particularly in response TLR 1/2 
stimulation and a generalised defect in TLR induced up-regulation of CD80 in 
monocytes compared to young individuals (van Duin, Allore et al. 2007; van 
Duin, Mohanty et al. 2007).  In a study using West Nile virus (WNV), a 
mosquito borne infection with disproportionate morbidity and mortality in older 
individuals, it was shown that interaction between the WNV envelope and the 
macrophage surface molecule dendritic cell-specific intercellular adhesion 
molecule-3-grabbing non-integrin (DC-SIGN) in vitro, reduced expression of 
TLR3 in macrophages of young people but not in the old (Kong, Delroux et al. 
2008).  It was speculated that this persistence of TLR-3 might mediate an 
exaggerated inflammatory response and the more severe WNV-induced 
disease seen in elderly sufferers.   
	  	  	  
	   46	  
Healthy older people appear to have similar proportions of conventional DCs 
and pDCs in blood compared to young people (Jing, Shaheen et al. 2009).  
The number of Langerhans cells in the skin have been shown to be reduced 
in old skin (Grewe 2001). The effects of ageing on the inflammatory response 
by different DC subsets and subsequent priming of T cells is complex with 
most studies showing impaired responses, some showing preserved 
responses and a few enhanced responses (Wong and Goldstein 2013). There 
is general agreement that ageing impairs the IFN I response by pDCs to viral 
infection (Jing, Shaheen et al. 2009; Sridharan, Esposo et al. 2011).  
 
1.5.3 Studying the effects of ageing on in vivo cutaneous DTH      
responses 
 
 
Murine models have provided useful insights into immune mechanisms but 
there are limitations to their use for investigating human ageing processes 
and cutaneous DTH responses.  Mice have considerably shorter lifespans yet 
have significantly longer telomeres suggesting telomere erosion, a 
characteristic finding of ageing in humans, is not as relevant in murine ageing 
(Kipling and Cooke 1990).  Also, loss of CD28 expression on memory T cells 
seen in humans with subsequent accumulation of this subset with ageing 
does not occur in mice (Ortiz-Suarez and Miller 2002).  DTH responses in 
mice are assessed by the degree of footpad or ear swelling whereas in 
humans the forearm is typically used.  Site related variations in DTH 
responses in humans have been reported and would presumably also apply 
between species (Wammanda, Gambo et al. 2006).  In mice the predominant 
T cell population in the skin resides in the epidermis and bears γ/δ TCRs 
whereas in humans T cells predominantly bear the α/β TCR and are found in 
the dermis (Elbe, Foster et al. 1996).  Also higher concentrations of antigen 
are required to elicit a DTH response in mice compared to humans (Mestas 
and Hughes 2004).  In addition there are differences in leukocyte transit 
times, polarisation of T cell populations and chemokines and chemokine 
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receptor expression between the two species (Mestas and Hughes 2004).  
Finally, VZV, the antigen of interest in this study, only produces clinically 
apparent infection in humans.   
 
However, studies in humans can be limited by ethical constraints and the 
difficulty in extricating relevant findings from the impact of confounding 
factors.  With this in mind, the SENIEUR protocol was designed in 1984 and 
defined strict admission criteria to immunologerontological studies to limit the 
influence of extrinsic factors such as disease and pharmacological 
interference (Ligthart, Corberand et al. 1984) allowing the study of ‘healthy 
ageing’.  However, study of this limited population using the SENIEUR 
protocol has suggested these elderly individuals have only modest changes in 
immune response but this does not reflect the circumstances of the majority of 
the aged population (Castle, Uyemura et al. 2001).  Strict application of the 
SENIEUR protocol has shown to exclude 70% of community dwelling old 
people who consider themselves to be healthy (Wick and Grubeck-
Loebenstein 1997) and as many as 90% of old people admitted to congregate 
housing (for those who are ‘self-supporting, reasonably healthy old people’) 
(Castle, Uyemura et al. 2001).  Some studies have used an ‘almost healthy’ 
elderly population who would be excluded from the SENIUER protocol due to 
one or two minor criteria.  Study of this ‘almost healthy’ elderly population 
does show significant differences in immune function compared to young 
individuals, not seen in the healthy old (Mysliwska, Bryl et al. 1999).  A 
modified version of the SENIUER protocol was also used in this thesis with a 
view to exclude significant co-morbidity and pharmacological interference but 
select a representative rather than exceptional group of old individuals. 
 
Previous in vivo human studies have shown that old individuals have a 
reduced ability to mount a cutaneous DTH response to recall antigens 
(Moesgaard, Lykkegaard Nielsen et al. 1987; Marrie, Johnson et al. 1988). 
Our group has shown that the reduced recall response to cutaneous PPD and 
C. albicans antigen seen in elderly humans does not reflect a global immune 
deficit since they show robust PBMC responses to antigen stimulation in vitro 
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(Agius, Lacy et al. 2009).  We have also shown that in the cutaneous DTH 
response to Candida albicans, there is a decreased ability of macrophages in 
the skin of older humans to secrete inflammatory cytokines such as TNF-a 
following antigen challenge (Agius, Lacy et al. 2009).  It is proposed that 
reduced pro-inflammatory cytokine secretion early in the DTH response to C. 
albicans fails to sufficiently activate dermal vessel endothelium to permit T cell 
entry and generate an adequate DTH response in the elderly. 
 
1.6 Aims and Objectives  
 
Ageing is associated with immune dysfunction.  This is reflected in the 
increased frequency and severity of infectious and non-infectious diseases.  
Whilst many studies use murine models of disease or focus on circulating 
leukocytes populations in humans, we aim to study a memory T cell response 
in vivo in humans to a clinically relevant antigen in the appropriate organ, in 
this case, VZV antigen in the skin.  By studying the immune response in the 
blood and skin of old people and comparing with it those in young people, we 
aim to gather pertinent data regarding the attenuation of cutaneous immunity 
during ageing in humans.  This is becoming an increasingly important 
challenge given the changing population demographic.   
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AIM 
 
To characterise the effects of ageing on the immune system in the skin in 
healthy old individuals. 
 
OBJECTIVES 
 
The objectives of this project were to: 
 
1. Compare the cutaneous clinical response with peripheral blood 
responses to VZV antigen in the old and young. 
 
 
2. Characterise and compare the kinetics and magnitude of the cellular 
response to intradermal injection of VZV antigen in the old and young. 
 
3. Characterise the relationship between VZV-specific memory CD4+ T 
cells and CD4+Foxp3+ Tregs that accumulate in response to the 
intradermal injection of VZV antigen.  
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Chapter 2.  Material and methods 
 
2.1 Volunteer recruitment 
 
This work was conducted with approval from the Ethics Committee of the 
Royal Free Hospital.  Healthy young individuals, aged 18 - 40 years (n=80, 43 
females, 37 males, median age 27.5 years) and healthy old individuals, 65 
years of age or above (n=36, 24 females, 12 males, median age 73.5 years), 
with a history of chickenpox were recruited into the study.  Exclusion criteria 
for entry into the study were based on a modified version of the clinical criteria 
stated in the SENIEUR protocol (Ligthart, Corberand et al. 1984) (Table 2.1).  
Laboratory analyses were not undertaken and individuals on prescribed 
mediation were not excluded unless the medication was known to be 
immunosuppressive in nature.  Whilst these latter deviations from the 
SENIEUR protocol may reduce the homogeneity of the group of elderly 
individuals studied, it allowed for more realistic recruitment into our study by 
increasing the number of potential volunteers, reducing the intrusive nature of 
the study by omitting initial screening blood tests, and reducing the number of 
visits involved for participants, whilst still being representative of a sample of 
the healthy ageing population.  Written informed consent was taken from each 
participant and study procedures were performed in accordance with the 
principles of the declaration of Helsinki. 
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Unable to give written informed consent 
Significant co-morbidity (renal impairment or failure, heart failure, diabetes) 
Past history of neoplasia in the last 10 years (excluding basal cell carcinoma) 
Previous treatment with chemotherapy or radiotherapy 
Immunosuppressive medication (systemic steroids in the last month or any other 
systemic immunosuppressant within the last 6 months) 
Recent infection or immunisation (within last month) 
Pregnancy or breast feeding 
Previous history of hypersensitivity to skin testing 
Known immunodeficiency 
History of chronic inflammatory disease 
 
Table 2.1 Exclusion criteria 	  	  
2.2 Skin testing 
 
Volunteers were given an intradermal injection of 0.02ml of VZV antigen (The 
Research Foundation for Microbial Diseases of Osaka University, BIKEN) into 
the medial aspect of the proximal forearm to induce a delayed type 
hypersensitivity response.  Correct administration into the intradermal 
compartment gave rise to a well-defined, short-lived, pale skin bleb at the site 
of injection.  This site on the forearm was used as it is relatively protected 
from sun exposure and hence relatively spared from the immunosuppressive 
effects of acute UV exposure and photo-ageing related to chronic sun 
exposure.  VZV antigen is prepared from VZV infected human diploid cells 
(Asano and Ahmed 1996; Takahashi, Okada et al. 2003).  For some of the 
experiments, volunteers were also injected intra-dermally with normal saline 
(0.02ml) in the contralateral forearm to provide an internal control for the 
detection of trauma-related changes secondary to the intradermal injection.  
Unfortunately the carrier solution for the VZV antigen, TCM-199, which would 
have provided an ideal control, is not commercially available for intradermal 
use in humans.  It contains amino aids and vitamins in addition to inorganic 
salts.    
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The response to the skin test antigen was measured typically between 48-72 
hours after intradermal injection. The following parameters: (i) diameter of 
induration (ii) palpability (iii) change in erythema from baseline, were 
assessed.  These were scored according to Table 2.2.  The final clinical score 
was calculated from the sum of these individual scores. 
 
Erythema was measured using a DermaSpectrometer (Cortex Technology, 
Hadsund, Denmark) (Figure 2.1B).  This is a portable, handheld instrument 
and consists of a light emitting diode and a photodetector to measure 
absorbed and reflected light from the skin, providing a numerical measure of 
erythema, the erythema index (EI).  The change in erythema index from 
baseline was calculated by subtracting the average of three readings taken 
from non-injected skin from the average of three readings taken over the 
injected site.  
 
 
Clinical Score 0 1 2 3 4 5 Score 
Change in 
Erythema-index (EI) 
 
0 1-5 6-10 11-15 >16   
Size of Induration 
(mm) 
 
0 1-5 6-10 11-15 16-20 >21  
Palpability Nil 
Just 
palpable 
Easily Marked 
Very 
marked 
  
      Total  
 
Table 2.2 Clinical scoring system 
 
 
2.3 Skin sampling 
 
A skin suction blister was raised or a 5mm punch biopsy was taken from the 
injected site at a given time point between 0 and 7 days after skin testing.  
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2.3.1 Suction blisters 
 
2.3.1.1 Suction blister induction 
 
Skin suction at low pressure over a few hours has shown to induce a split 
between the epidermis and dermis at the level of the lamina lucida giving rise 
to a blister (Kiistala 1968) and the blister fluid contained is representative of 
skin interstitial fluid (Rossing and Worm 1981).  To induce a skin suction 
blister, negative pressure of 25-40kPa (200-300mmHg below atmospheric 
pressure) was applied via a suction chamber (Medical Engineering, Royal 
Free Hospital, UK) positioned over the site of skin testing for 2-4 hours using 
a portable clinical suction pump (VP25, Eschmann, Lancing, UK) (Figure 2.1).  
Suction was applied until a unilocular blister measuring 10-15mm was formed. 
The blister was protected overnight with a rigid adhesive dressing assembled 
using a Comfeel plus ulcer dressing (Coloplast, Peterborough, UK), a 
universal top (Sterilin, Fisher Scientific UK Ltd, Loughborough, UK), Micropore 
tape (3M healthcare, Loughborough, UK) and Tubigrip bandaging (Seton 
Healthcare Group plc, Oldham, UK). 
 
The following day, approximately 18-24 hours after induction, the blister fluid 
was aspirated using a sterile 21G needle and a 2ml syringe (Terumo Europe, 
Belgium).  The time lag between blister induction and aspiration was to allow 
cells from the site of antigen challenge in the skin to accumulate in the blister 
fluid.  The recorded time of sampling was from the time of VZV antigen 
injection up to the time of blister fluid aspiration.  Blister fluid was suspended 
in 1.5ml conical tubes (Alpha Laboratories Ltd, Eastleigh, UK).  The blistered 
site was sprayed with Betadine dry powder spray (Seton Healthcare Group 
plc, Oldham, UK) and the site dressed with a Cosmopor E dressing 
(Hartmann, Heywood UK).  Volunteers were advised to leave the dressing in 
place and to keep it dry for 48 hours before removing and leaving the wound 
open to the air.  The suction cups were dismantled after use and disinfected in 
Barrycidal 36 (Heraeus Instruments Ltd, Brentwood, Essex, UK) for a 
minimum of 24 hours. 
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Figure 2.1: The clinical DTH response in the skin and skin suction blister 
Induction 	  
(A) DTH responses were induced by intradermal injection of VZV antigen in 
volunteers with a history of chickenpox.  Clinical responses were assessed 48-72 
hours after injection by palpability, induration and erythema.  (B) The erythema index 
was measured using a DermaSpectrometer to provide objective values.  (C,D) 
Suction chambers were made up of a nylon cup, a transparent Perspex lid and a 
template. The size of the template used was adjusted according to the size of the 
clinical response. Rubber O-rings were used between the components to allow an 
airtight seal to be formed when the chamber is assembled.  (E,F) Suction chambers 
were connected to a portable clinical suction pump via sterile disposable tubing and 
positioned securely over the injected skin site. (F) Suction blisters were induced by 
applying negative pressure (25-40kPa (200-300mmHg) over 2-4 hours. (G) The 
formed blister was protected overnight using a rigid universal container top placed 
over a 5x5cm Comfeel dressing, secured with micropore tape. (H) The blister was 
aspirated 18-24 hours after formation using a sterile 21G needle and a 2ml syringe.  
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2.3.1.2 Suction blister cell isolation  
 
Blister fluid was microcentrifuged at 3000 rpm for 4 minutes (Heraeus Biofuge 
Pico) to pellet the cellular contents.  The supernatant was removed and the 
cell pellet was re-suspended in 500µl of RPMI 1640 containing 10% human 
AB serum, 100U/ml penicillin, 100µg/ml streptomycin and 2mM L-glutamine 
(all from Sigma Aldrich, Gillingham, Dorset, UK).  
 
2.3.1.3 Counting of blister cells 
 
Blister mononuclear cell numbers were counted using a haemocytometer.  
Tryptan blue was used to assess cellular viability.  A 10µl aliquot of blister cell 
suspension was mixed 1:1 with Trypan blue (Sigma-Aldrich, Gillingham, 
Dorset, UK) and viable non-stained cells were counted. 
2.3.2 Skin biopsy 
 
2.3.2.1 Biopsy procedure 
 
A 5mm punch biopsy (Steifel, Sligo, Ireland) was taken of the centre of the 
injected skin test site or of normal skin.  Prior to biopsy the area was infiltrated 
with 1% lidocaine hydrochloride local anaesthetic (Hameln Pharmaceuticals 
Ltd, Gloucester, UK).  Biopsy wounds were closed with a 4.0 Ethilon 
polyamide non-absorbable suture (Johnson & Johnson Intl, Belgium) and the 
site dressed with a Cosmopor E dressing (Hartmann, Heywood, UK).  
Volunteers were advised to leave the dressing in place and keep it dry for 24 
hours before removing and leaving the wound open to air.  The suture was 
removed after 7 days.  Skin biopsies were transported to the laboratory in 
sterile gauze soaked in saline within 15 minutes of obtaining it to prevent 
desiccation of the skin sample. 
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2.3.2.2 Biopsy storage and sectioning  
 
Biopsies were mounted in OCT (optimal cutting temperature compound; 
Bright Instrument Company Ltd, Huntingdon, UK) on cork disks, orientated 
with the epidermis perpendicular to the cork disk, and snap frozen in 
isopentane (Sigma-Aldrich, Gillingham, Dorset, UK) cooled in liquid nitrogen. 
The samples were stored in a freezer at -80°C.  6µm frozen sections were cut 
at -20°C using a Bright 5040 microtome (Bright Instrument Company Ltd., 
Huntingdon, UK) on to poly-L-lysine coated glass slides (Sigma-Aldrich, 
Gillingham, Dorset, UK).  Poly-L-lysine coated slides were used to help the 
skin section adhere to the slide. Two sections were mounted on to each slide. 
The sections were left overnight to air-dry and then fixed in fresh acetone for 
10 minutes, followed by 99% ethanol for 10 minutes. The sections were air-
dried for a further 10 minutes and then wrapped individually in cling-film and 
stored in a freezer at -80°C. 
 
2.4 Blood sampling and PBMC isolation 
 
Heparinised blood was collected from volunteers prior to VZV skin test 
antigen injection or at the time of blister aspiration.  Heparinised blood was 
mixed with an equal volume of Hanks Balanced Salt Solution (HBSS) (Sigma 
Aldrich, Gillingham, Dorset, UK) and layered on to Ficoll-Paque (Amersham 
Biosciences UK Ltd, Chalfont St. Giles, UK) in 50ml Falcon tubes. This was 
centrifuged for 20 minutes at 2000rpm with no brake.  The buffy coat at the 
interphase layer was retrieved and washed in excess HBSS twice, with 
centrifugation at 1800rpm and 1200rpm for 10 minutes after the first and 
second wash respectively. The cell pellet was then re-suspended in complete 
medium (RPMI 1640 containing 10% human AB serum, 100U/ml penicillin, 
100µg/ml streptomycin and 2mM L-glutamine (all from Sigma Aldrich, 
Gillingham, Dorset, UK)). Typically, 0.5-2 x106 cells were isolated per 1ml of 
venous blood.  
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2.5 Immunohistology 
 
2.5.1  Antibodies used in the study 
 
Antigen Source Clonea Isotype Dilution Amplification/Detectionb 
INDIRECT IMMUNOFLUORESCENCE 
CD4  
Biotin 
 
BD 347321 SK3 IgG1, κ 1:50 Streptavidin-Cy3 1:100  
CD4  
Leu-3a 
BD 346320 SK3 IgG1 1:10 Donkey anti-mouse IgG 
AlexaFlour488 1:200 
  
CD8 
biotin 
BD 555365 
 
RPA-T8 IgG1, κ 1:50 
 
Streptavidin-Cy3 1:100  
Foxp3 
biotin 
E-
biosciences 
13-4776-82 
PCH101 Rat 
IgG2a, κ 
1:100 
o/n 
Streptavidin-Cy3 1:100  
CD62E 
biotin 
 
Abcam 
36688 
ENA1 IgG1 1:50 Streptavidin-Cy3 1:100  
CD163 
 
 
Acris 5C6-
FAT 
IgG1 1:100 Goat anti-mouse IgG1 
AlexaFluor568, 1:250  
CD11c 
 
 
BD 550375 B-ly6 IgG1 1:100 Goat anti-mouse IgG1 
AlexaFluor568, 1:250 
AlexaFluor488, 1:250 
BDCA-1 
 
Miltenyi AD5-
8E7 
IgG2a 1:100 Goat anti mouse IgG2a 
AlexaFluor568, 1:250 
TNF-α 
FITC 
BD 6401.11
11 
IgG 1:10 Goat IgG A488 anti-
fluorescein/Oregon, 1:200 
DIRECT IMMUNOFLUORESCENCE 
Ki67 
FITC 
 
BD 556026 B56 IgG1, κ 1:50  
CD31 
FITC 
 
BD 555445 WM59 IgG1, κ 1:50  
 
Table 2.3 Antibodies used for Immunofluorescence 
o/n = overnight 
a = all are murine monoclonal antibodies unless stated 
b = all detection antibodies are from Invitrogen with the exception of Streptavidin-Cy3 
(Cedarlane labs Ltd. CLCSA1010) 
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Antigen Source Clonea Isotype Dilution Detection, developing 
agent 
Neutrophil 
elastase 
Dako NP57 IgG1, κ 1:200 Biotinylated horse anti-
mouse antibody; avidin-
biotinylated enzyme 
complex (VECTASTAIN 
ABC, Vector 
Laboratories); AEC 
BDCA-2 
 
Miltenyi AC144 IgG1 1:10 
CD4  
 
BD 
340133 
SK3 IgG1, κ 1:100 
BDCA-3  Miltenyi AD5-
14H12 
IgG1 1:20 
DC-LAMP Beckman 
Coulter 
104.G4 IgG1 1:50 
CD11c 
 
BD B-ly6 IgG1, κ 1:100 
CD163 
 
Acris 5C6-FAT IgG1 1:100 
 
Table 2.4 Antibodies used for Indirect Immunohistochemistry 
 
a = all are murine monoclonal antibodies unless stated 
AEC = 3-amino-9-ethyl carbazole 
2.5.2 Indirect Immunofluorescence 
 
In this technique a primary unconjugated antibody is used to detect the 
antigen of interest in a tissue section.  A secondary fluorescently labelled 
antibody, raised in a different animal host and specific for the animal and 
immunoglobulin class of the primary antibody is then added and allowed to 
bind the primary antibody.  The fluorescent signal, which is representative of 
the presence of the antigen of interest, can then be visualised using a 
fluorescence microscope.  Multiple secondary antibodies may bind the 
primary antibody and in this way also amplifies the signal generated.  The 
primary and secondary antibodies used in this study are shown in table 2.3.  
In some cases, a directly conjugated primary antibody was used e.g., CD31 
FITC, Ki67 FITC, and these signals did not require an amplification step i.e. 
direct immunofluorescence.  For TNF-α FITC, a secondary anti-FITC antibody 
was used to amplify the signal.  Where the simultaneous presence of two 
antigens in a single tissue section is being investigated, it is preferable for the 
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primary antibodies to be raised in different animal hosts to reduce the risk of 
the secondary antibodies binding to both primary antibodies.  
 
Slides mounted with 6um skin sections as described above and stored at  
-800C were placed in a moist staining box at room temperature for 15minutes 
before being unwrapped from their cling film cover.  Each section was then 
circled with a Dako pen (Dakocytomation, Glostrup, Denmark) that provides a 
water repellent barrier preventing escape of solutions applied to the sections.  
A drop of freshly prepared 1xPBS(Sigma Aldrich) (dissolve 2 PBS tablets in 
400ml sterile water) was added to each ringed section to prevent drying of the 
tissue. Slides were placed in a slide rack and washed in 1xPBS in a glass 
container for 5 minutes.  Excess PBS was removed by tapping the slide and a 
drop of Dako non-serum protein block (Dakocytomation, Glostrup, Denmark) 
was added to the ringed sections for 20 minutes to reduce non-specific 
antibody binding.  The blocking agent was removed by tapping the slide and 
the primary antibody, diluted in 1xPBS at a predetermined dilution, was added 
to each section (50µl/section).  Slides were left to incubate at room 
temperature in the dark for 1 hour.  For Foxp3 staining the primary antibody 
was left to incubate overnight as a prolonged incubation period results in 
better staining with this antibody.   
 
At the end of the incubation period with the primary antibody, slides were 
washed in 1x PBS for 5 minutes in the dark, twice.  Excess PBS was removed 
by tapping the slide and secondary antibody diluted in 1xPBS (50µl/section) 
was added to each section and left to incubate at room temperature in the 
dark for 45 minutes.  Next, slides were washed for 10 minutes in 1xPBS in the 
dark, twice.  Filter paper was used to blot any remaining PBS from the slide 
and sections were mounted with Vectashield containing DAPI (Vector 
Laboratories Ltd, Peterborough, UK) and covered with a 22x22mm square 
coverslip.  Vesctashield mounting media remains a viscous liquid on the slide 
preventing the sections from drying out and reduces photo-bleaching.  The 
coverslips were secured with clear nail varnish and the slides were placed in a 
slide holder and stored in the dark at -200C.    
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Staining for co-expression of TNF-α with either CD163 or CD11c, and CD11c 
expression with BDCA-1 was performed by Dr M. Vukmanovic-Stejic and Dr 
J. Duculan-Fuentes in Professor J. Krueger’s laboratory at the Rockefeller 
University in New York using a slightly different protocol.  Skin sections were 
blocked in 10% normal goat serum (Vector Laboratories Ltd) for 30 minutes.  
Primary antibody to CD163 or CD11c was diluted in 10% goat serum and 
sections were incubated overnight at 40C.  A secondary goat anti-mouse IgG1 
antibody conjugated with Alexa Fluor 568 was added followed by overnight 
incubation with directly conjugated TNF-α FITC and amplified with goat anti-
FITC Alexa Fluor 488. 
 
2.5.2.1 Biotin-Streptavidin Cy3 technique 
 
Some of the primary antibodies used were biotinylated e.g. Foxp3, CD8 and 
CD4.  The detection and amplification step in these cases was performed 
using streptavidin protein conjugated to the fluorochrome.  Biotin binds 
streptavidin with a high affinity and specificity.  The protocol for their use in 
indirect immunofluorescence was exactly the same as described above.  
 
2.5.2.2 Control slides 
 
Control slides were used to distinguish between specific antigen binding and 
that due to background autofluorescence e.g. from the collagen fibres in the 
dermis as well as any non-specific binding of the secondary antibodies.  
Tissue sections known to express the antigen(s) of interest i.e. positive 
controls, tissue sections where the antigen of interest is expected to be 
absent i.e. negative controls, tissue sections stained with just the secondary 
antibody to detect non-specific binding as well as isotype controls were used 
as needed, to allow correct determination of the fluorescent signal.   
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2.5.2.3 Quantification of Immunofluorescence  
 
Images were acquired using appropriate filters of a Leica DMLB microscope 
with Leica N PLAN 20 or 40 objective and a Cool SNAP-Pro cf Monochrome 
Media Cybernetics camera, controlled by Image-Pro PLUS 6.2 software. 
When counting the numbers of cells in perivascular infiltrates (PVs), the five 
largest PVs present in the upper and mid-dermis of each section were 
counted.  Cell numbers were expressed as the mean absolute cell number 
per PV.  In normal skin, the five largest accumulates present in the upper and 
mid-dermis of each section were counted.  When assessing the expression of 
E-selectin on CD31 expressing endothelial cells, the entire upper and mid-
dermis of the section was examined.  Slides were assessed by one of two 
researchers and reviewed by both if there were any uncertainties. 
2.5.3 Indirect Immunohistochemistry 
 
The biotin-avidin technique that employs the extremely strong avidin – biotin 
interaction was used.  This technique uses a primary unconjugated antibody 
to detect the antigen of interest in the tissue section.  A secondary biotinylated 
antibody raised in another animal host and specific for the animal and 
immunoglobulin class of the primary antibody binds the primary antibody.  
Avidin conjugated to a biotinylated horseradish peroxidase (avidin and 
biotinylated horseradish peroxidase macromolecular complex (ABC)) binds 
the biotinylated secondary antibody.  Finally the chromogen 3-amino-9-ethyl 
carbazole (AEC), a peroxidase substrate is added and gives rise to a 
red/brown colour where it encounters ABCs and hence the brown colour seen 
under a light microscope is representative of the presence of the antigen of 
interest.  Table 2.4 lists the primary antibodies used in this study.  
 
Slides mounted with 6um skin sections as described above and stored at  
-800C were placed in a moist staining box at room temperature for 15 minutes 
before being unwrapped from their cling film cover.  Slides were washed in 
1xPBS for 5 minutes.  Excess PBS was removed by tapping the slides and 
	  	  	  
	   62	  
sections were incubated with 50µl of 10% normal horse serum (prepared from 
the same species in which the secondary antibody is made) for 20 minutes. 
The slides were tapped again to remove the blocking serum before adding 
50µl of the primary antibody diluted in 1% normal horse serum to each 
section.  Sections were left to incubate overnight at 40C.  Slides were rinsed 
by brief immersion in 1xPBS twice to remove unbound primary antibody 
before being washed in 1xPBS for 5 minutes.  At this stage, ABC is prepared 
from a commercially available kit, Vectastain Elite ABC kit (Vector 
laboratories) by allowing 10µl of agent “A” (Avidin DH) and 10µl of agent “B” 
(biotinylated enzyme) to react in 1000µl of 1% normal horse serum diluted in 
PBS.  The substrate AEC is prepared by dissolving 120mg of AEC in 15ml of 
N, N-dimethyl formamide (Sigma Aldrich).  0.1M acetate buffer is prepared by 
adding 79ml of 0.1M sodium acetate (13.61 g/L distilled H20 and 21ml of 0.1M 
Acetic acid).  The mixture is filtered through a 0.2 micron filter with a syringe 
and 2.5µl of 30% H202 is added to activate the reagent.  AEC substrate was 
prepared in advance by Dr. J. Fuentes-Duculan in Professor J. Krueger’s 
laboratory at the Rockefeller University in New York when skin sections were 
stained in their laboratory.  Slides were tapped to remove PBS and sections 
were each incubated with 50µl of horse anti-mouse biotinylated secondary 
antibody diluted in 1% normal horse serum (1:200) for 30 minutes at room 
temperature.  Slides were rinsed again by immersing twice in 1xPBS and then 
placed in 0.3% H2O2 (1:10 dilution of 3% Henry Schein Hydrogen peroxide 
solution in distilled water) for 15 minutes to ensure quenching of endogenous 
peroxidase.  Slides were rinsed by immersing in 1xPBS twice and then 
washed in 1xPBS for 5 minutes.  Excess PBS was removed by tapping slides 
and sections were incubated with VECTASTAIN ABC for 30 minutes at room 
temperature (50µl per section).  The slides were rinsed and washed in PBS 
again before the AEC reagent was applied.  Sections were closely monitored 
by repeated examination under a light microscope until the desired staining 
intensity developed.  The slides were rinsed several times in distilled water 
and left to dry. The dry sections were mounted in aqueous mounting medium 
and covered with a square 22mm x 22mm coverslip. 
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2.5.3.1 Quantification of Immunohistochemistry 
 
Slides were visualised using a light microscope (Nikon Eclipse E600) and a 
digital camera (Nikon DXM1200F camera with Eclipse Net software).  In all 
cases, a field with a pre-determined area (1x1.2mm) was centred on the 
digital image with the epidermis at the top of the field, and the number of cells 
within it were counted manually using computer assisted image analysis 
software (Image J) (NIH Image 6.1;http://rsb.info.nih.gov/nih-image).  Where 
more than a single frame was needed to examine the upper and mid dermis 
of the entire section, the average of the counts per field was used for analysis. 
Slides were assessed by one of two researchers and reviewed by both if there 
were any uncertainties. 
 
2.6 Flow cytometry 
 
Flow cytometry was used to analyse stained PMBCs and blister cells and was 
performed on BD LSR Fortessa or BD LSR II (both Becton Dickinson, NJ, 
USA) flow cytometers which have 4 and 5 lasers respectively, using FACS 
Diva software.  FlowJo software (TreeStar, Inc) was used to further analyse 
the flow cytometer read out. Forward and side scatter profiles were used to 
identify the lymphocyte population.  Dead cells and debris were excluded and 
the cells of interest further analysed according to the presence of cell 
markers.  Single colour fluorochrome controls were used in each experiment 
to allow compensation of overlapping emission spectra from the different 
fluorochromes prior to each sample acquisition.  Isotype controls were used to 
delineate positive populations where positive and negative populations were 
not clearly distinguishable.  The antibodies and the concentration at which 
they were used for flow cytometry are shown in Table 2.5. 
 
2.6.1 Surface staining by direct immunofluorescence 
 
Monoclonal antibodies directly conjugated to a specific fluorochrome were 
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used to detect the expression of cell surface markers.  100µl aliquots of 
PBMC or blister cell suspension were placed in 5ml FACS tubes (Falcon, 
Becton Dickinson, NJ, USA).  Surface antibodies were added and the 
samples incubated in the dark at 40C for 30 minutes.  Samples were washed 
with 2ml PBS and centrifuged at 1800rpm for 5minutes.  The supernatant was 
decanted and the cells re-suspended in 200µl of 0.5% paraformaldehyde 
(Sigma-Aldrich, Gillingham, Dorset, UK) in PBS.  Samples were stored at 40C 
in the dark until run on the flow cytometer.  
 
2.6.1.1 Detection of antigen-specific T cells  
 
A MHC class II tetramer, HLA-DRB1*1501 iTAg MHCII tetramer (Beckman 
Coulter) complexed to VZV IE63 peptide 24 (amino acids 229-243, 
QRAIERYAGAETAEY), was used to detect VZV specific cells in samples 
taken from volunteers known to be HLA-DRB1*15 positive.  CLIP peptide 
(PVSKMRMATPLLMQA) was used as a control.  In these experiments, 100µl 
aliquots of PBMC containing 1x106 cells and100µl blister cell suspension 
containing between approximately 20,000 – 300,000 cells were incubated with 
2µl/ml tetramer at 370C in a humidified 5% CO2 atmosphere for 1-2 hours in 
the dark, washed with 2ml PBS and centrifuged at 1500rpm for 5 minutes 
prior to addition of other surface antibodies.  Subsequent washes were also 
followed by centrifugation at 1500rpm rather than 1800rpm in samples 
containing tetramer.  
2.6.2 Intracellular staining  
 
Intracellular staining was used to detect cytokine production by antigen 
specific cells after in vitro stimulation, proliferating cells by their expression of 
Ki67, and potential Tregs expressing Foxp3.  In order to stain for cytokines, 
PBMCs and blister cells were fixed and permeabilied  (Fix & Perm ® Cell 
Permeabilisation Kit; Caltag Laboratories) to allow antibodies to access the 
cytoplasm whilst maintaining the morphological scatter characteristics of the 
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cells.  If a combination of both surface and intracellular antigen staining was 
required, cells were first incubated with surface antibodies as detailed above, 
washed with PBSA and centrifuged at 1800rpm for 5 minutes.  The 
supernatant was decanted and the cell pellet re-suspended in 100µl of 
reagent A (Fixation medium containing formaldehyde) and left to incubate at 
room temperature for 15 minutes in the dark.  Samples were washed with 
PBS and centrifuged for 5 minutes at 1800rpm. The supernatant was 
decanted and the cells re-suspended with 100µl of reagent B 
(Permeabilisation medium) and directly conjugated antibodies to the 
intracellular proteins of interest were added.  Samples were left to incubate at 
40C in the dark for 30 minutes.  The cells were finally washed with PBSA (1% 
w/v bovine serum albumin and 0.02% sodium azide (both Sigma-Aldrich, 
Gillingham, Dorset, UK), centrifuged at 1800rpm for 5 minutes, the 
supernatant was decanted, and the cells re-suspended and fixed in 200µl of 
2% paraformaldehyde in PBS.  Samples were stored in the dark at 40C until 
they were analysed on the flow cytometer.  
 
When samples were stained for Foxp3 or Ki67 expression, the Foxp3 Staining 
Buffer Set (Miltenyi Biotec) was used according to the manufacturer’s 
instructions instead for fixation and permeabilisation.  Briefly, after incubation 
with surface antibodies, samples were washed in PBS, centrifuged and the 
supernantant decanted as described above.  Cells were re-suspended in1ml 
of freshly prepared fixation-permeabilisation solution (Fixation medium 
containing formaldehyde) and were left to incubate in the dark at 40C for 
30minutes.  1ml of freshly prepared permeabilisation buffer solution was then 
added, and samples centrifuged at 1800rpm for 5minutes.  The supernatant 
was decanted and this wash step repeated.  Directly conjugated antibodies to 
the intracelluar antigens of interest were added and left to incubate for 
30minutes at 40C in the dark.  Samples were washed once more with 1ml of 
permeabilisation buffer, centrifuged at 1800rpm for 5 minutes, the supernatant 
decanted and the cells fixed in 200µl of 2% paraformaldehyde as described 
above.  In samples where both surface staining with the tetramer agent and 
intracellular staining for Foxp3 expression was required, all centrifugation 
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occurred at 1500 rpm when the tetramer was added and 1700rpm once the 
antibody to FoxP3 was added.  These variations in centrifugation speeds 
were a compromise between the optimum required for each of the agents.  In 
cases where cytokines and either KI67 or Foxp3 were stained for together, 
the Foxp3 staining protocol was used.  
 
Antigen Clonea Isotype Dilution Source 
Ki67 FITC 
 
B56 mIgG1,κ 1:10 BD 556026 
CD3 APC 
 
UCHT1 mIgG1,κ 1:15 BD 555335 
CD3 ECD UCHT1 mIgG1 1:100 Beckman 
Coulter A07748 
CD4 PECy-7 
 
SK3 mIgG1,κ 1:20 BD 557852 
CD4 APC-H7 
 
RPA-T4 mIgG1,κ 1:20 BD 560158 
CD4 Alexa 
Fluor® 700 
RPA-T4 mIgG1,κ 1:50 BD 557922 
CD4 PerCP 
 
SK3 mIgG1,κ 1:10 BD 345770 
CD8 PerCP 
 
SK1 mIgG1,κ 1:10 BD 345774 
CD8 APC 
 
RPA-T8 mIgG1,κ 1:10 BD 555369 
CD8 FITC 
 
SK1 mIgG1 1:10 BD 345772 
CD45RA FITC 
 
HI100 mIgG2b,κ 1:10 BD 555488 
CD45RA 
Alexa Fluor® 
700 
HI100 mIgG2b,κ 1:20 BD 560673 
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CD45RA PE-
Cy7 
L48 mIgG1 1:25 BD 337186 
CD27 APC-H7 
 
M-T271 mIgG1,κ 1:20 BD 560222 
CD28 FITC 
 
CD28.2 mIgG1,κ 1:10 BD 555728 
CD28 PE 
 
CD28.2 mIgG1,κ 1:12.5 BD 555729 
CLIP  PE 
 
N/A N/A 1:50 Beckman Coulter 
Tetramer PE 
 
N/A N/A 1:50 Beckman Coulter 
CD127 Alexa 
Fluor® 647 
HIL-7R-M21 mIgG1,κ 1:10 BD 558598 
CD127 V450 
 
HIL-7R-M21 mIgG1,κ 1:20 BD 560823 
CD127 PE 
 
HIL-7R-M21 mIgG1,κ 1:25 BD 557938 
CD25 PE-Cy7 
 
M-A251 mIgG1,κ 1:20 BD 557741 
CD39 FITC 
 
A1 mIgG1 1:33 Abcam 30423 
Foxp3 Pacific 
Blue 
206D mIgG1,κ 1:20 Biolegend 320116 
Foxp3 APC 3G3 mIgG1 1:10 Miltenyi 
 
Foxp3-APC PCH101 mIgG1, 1:10 eBioscience 
 
CD14 PerCP 
 
MφP9 mIgG2b,κ 1:10 BD 345786 
CD19 PerCP 
 
4G7 mIgG1,κ 1:10 BD 345778 
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IFNγ V450 
 
B27 mIgG1,κ 1:200 560371 
IFNγ APC 
 
B27 mIgG1,κ 1:200 554702 
IL-2 PE 
 
JES6-5H4 Rat IgG2b 1:10 Miltenyi 
IL-2 FITC 
 
5344.111 mIgG1 1:10 BD 340448 
IL-10 Alexa 
Fluor® 488 
JES3-9D7 Rat IgG1,κ 1:20 Biolegend 501411 
IL-17 Alexa 
Fluor® 700 
N49-653 mIgG1,κ 1:20 BD 560613 
Viaprobe - Cell 
Viability 
Solution 
N/A N/A 1:20 BD 555816 
LIVE/DEAD – 
Cell Viability 
Kit 
N/A N/A 1:200 Invitrogen 889457 
 
Table 2.5 Antibodies used for flow cytometry  
 
2.7 In Vitro Cell Culture 
 
The following were used to identify functional VZV-specific cells: 
2.7.1 Overnight Stimulation Assay 
 
Antigen-specific CD4+ T cells were identified using flow cytometry to detect 
cells containing IL-2 or IFN-γ after short term incubation with VZV lysate in the 
presence of brefeldin A.  Brefeldin A enhances staining of intracellular 
cytokines by preventing their secretion from the cell by interfering with 
intracellular transporting mechanisms.  PBMCs (1x106) or blister cell 
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suspension were incubated in sterile FACS polypropylene tubes (Elkay 
Laboratory Products, Hampshie, UK) with VZV lysate (Virusys) at a final 
concentration of 40µl/ml for 15 hours at 370C in a humidified 5% CO2 
atmosphere.  After 2 hours of incubation Brefeldin A (Sigma-Aldrich, 
Gillingham, Dorset, UK) was added at a final concentration of 5µg/ml.  A non-
stimulated control and a positive control, the superantigen Staphylococcal 
exotoxin B added at a final concentration of 1µl/ml (Sigma-Aldrich, Gillingham, 
Dorset, UK), were also included. At the end of the incubation period, the 
samples were centrifuged at 1800rpm for 5 minutes. The supernatant was 
decanted and the cells re-suspended in PBS.  Staining for intracellular 
cytokines was performed according to the protocol described above. 
2.7.2 Ki67 Proliferation Assay 	  
Antigen-specific CD4+ T cells were identified using flow cytometry to detect 
cells expressing Ki67, a cellular marker for proliferation, after incubation with 
VZV lysate.  Ki67 is present during all active phases of the cell cycle but is 
absent from resting cells.  PBMCs (0.5x106 cells) suspended in complete 
medium were incubated with VZV lysate (Virusys) at a final concentration of 
4µl/ml in a 48 well plate (Falcon, Becton Dickinson Labware).  Samples were 
incubated at 370C in a humidified 5% CO2 atmosphere for 3 days.  A non-
stimulated negative control was included.  At the end of the incubation period, 
the contents of the wells were centrifuged at 1800rpm for 5 minutes and the 
supernatant decanted.  Cells were washed by re-suspending in PBS, 
centrifuging again at 1800rpm for 5 minutes and were then finally re-
suspended in PBS.  Staining for Ki67, an intracellular protein, was performed 
according to the protocol described previously. 
 2.7.3  [3H] Thymidine Incorporation Assay 	  
In this assay, radiolabelled thymidine is incorporated into new strands of DNA 
synthesized during cell division.  The radioactivity from the sample is 
measured using a scintillation beta-counter and reflects the degree of cell 
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division that has occurred.  VZV-specific CD4+ T cells would be expected to 
proliferate in response to incubation with VZV lysate.  200µl aliquots of 
PBMCs suspended in complete medium at a concentration of 1x106 cells/ml 
were added to a 96 well round bottomed tissue culture plate (Falcon, Becton 
Dickinson).  VZV lysate (Virusys) was added to give a final concentration 
range of between 0-10µl/ml.  Samples at each concentration were set up in 
triplicate. The cells were incubated for 6 days at 370C in a humidified 5% CO2 
atmosphere before adding 10µl of 0.0025MBq [3H] thymidine (Amersham 
Biosciences UK Ltd, Chalfont St. Giles, UK) to each well and incubating for a 
further 16 hours.  Plates were stored at -200C until a time when they could be 
harvested onto glass fibre filter strips using a cell harvester (Wallac 1450 
MicroBeta Trilux Liquid Scintillation & Luminescence Counter).  Counts per 
million (cpm) from incorporated [3H] thymidine were determined by liquid 
scintillation counting and the mean value of triplicate wells used for data 
analysis. 
 
 
 2.8 Statistics 
 
Statistical analysis was performed using GraphPad Prism version 7.00 for 
Windows (GraphPad Software, San Diego, California, USA).  Non-parametric 
tests were predominantly used as the data could not be assumed to be 
normally distributed.  The Mann-Whitney U test was used when comparing 
only two unpaired groups, and the Kruskall-Wallis test for comparing three or 
more unpaired groups.  The Wilcoxon matched pairs test or a paired t test 
was used when comparing two groups of matched data.  Linear regression 
analysis was used to assess correlation between clinical score and both the 
number of infiltrating perivascular T cells and proportion of Tregs. 
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Chapter 3:  Cutaneous clinical and peripheral blood 
responses to VZV antigen in old and young individuals  
 
3. 1 Introduction 
 
Varicella zoster virus is an exclusive human herpes virus that infects most 
individuals in childhood in European countries (Bonanni, Breuer et al. 2009) 
causing chickenpox.  Following resolution of the acute illness, VZV becomes 
latent and persists life-long in neurons. Reactivation of latent VZV causes 
herpes zoster (HZ), more commonly referred to as shingles, characterized by 
pain and a rash typically limited to a single dermatome, corresponding to the 
sensory ganglion in which latent VZV reactivated.  Post herpetic neuralgia, 
where pain persists in an area previously affected by HZ is the major 
complication of HZ.  It is established that adequate VZV-CMI is necessary to 
prevent HZ, although the mechanism of prevention is not known.  VZV-
specific T cells may interact directly with neurons to prevent VZV reactivation, 
although VZV-specific T cells, in contrast to herpes simplex virus, have not 
been detected in human sensory ganglia (Verjans, Hintzen et al. 2007).  
Alternatively VZV-specific T cells may respond rapidly in the event of 
reactivation limiting the infection before it can become clinically apparent 
(Quinlivan, Ayres et al. 2007; Cohrs, Mehta et al. 2008; Malavige, Jones et al. 
2008).  Both periodic asymptomatic reactivation and external exposure to VZV 
e.g. contact with children with chickenpox, may potentially boost VZV-specific 
T cells.  Despite this the incidence of HZ increases with age from between 5-
6.5 per 1000 individuals at age 60 years to 8-11 per 1000 individuals at age 
70 (Donahue, Choo et al. 1995) in keeping with the age-related decline in 
VZV cell mediated immunity (Sadaoka, Okamoto et al. 2008). 
 
A skin test containing VZV antigen has been used to determine CMI to VZV 
and skin responses decline with increasing age (Burke, Steele et al. 1982; 
Sadaoka, Okamoto et al. 2008).  The clinical response to the VZV skin test 
has been shown to correlate with the VZV-specific CMI measured by the   
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IFN-γ Enzyme-Linked Immunospot Assay (ELISPOT) (Sadaoka, Okamoto et 
al. 2008).  In this chapter we compare clinical responses to this VZV skin test 
between old and young volunteers and see how this relates to peripheral 
blood responses to VZV antigen.  
 
3.2 Clinical response to VZV skin test  
 
61 young (40 years) and 29 old (>65 years) individuals were tested with 
0.02ml of VZV antigen solution injected intradermally into the inner aspect of 
the proximal forearm.  The clinical response to the skin test was assessed 
between 48 and 72 hours after injection, for erythema, diameter of induration 
and ease of palpability, and was assigned a clinical score based on these 
parameters (Table 2.2). The sum of the clinical scores in each age group was 
used to calculate a mean score for both groups. The clinical response to VZV 
skin test antigen was significantly diminished in old individuals compared to 
young (***p=<0.0001, Mann Whitney test) (Figure 3.1). 
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Figure 3.1 Cutaneous clinical responses to VZV antigen in young and old individuals. 
 
Old (n=29) and young (n=61) volunteers were injected with 0.02ml VZV antigen 
solution intradermally. The clinical response was assessed at 48-72 hours for 
erythema, diameter of induration and ease of palpability and a clinical score was 
assigned based on these parameters. (A) A photograph of the clinical response to 
VZV skin test antigen 3 days after the injection in a young and an old individual. (B) 
Graph shows cumulative data (n=90) and mean of clinical score in old and young 
individuals. The clinical score was significantly reduced in the old compared to the 
young volunteers (***p=<0.0001, Mann Whitney test). 	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3.3 Peripheral blood response to VZV lysate  
 
We next investigated whether the reduced cutaneous response to VZV 
antigen in old volunteers reflected a reduced circulating immunity to VZV.  We 
investigated the proliferative capacity of VZV specific cells and their ability to 
produce inflammatory cytokines in response to VZV lysate in vitro. 
 
Freshly isolated PBMCs from old (n=19) and young (n=19) individuals were 
stimulated with a range of concentrations of VZV lysate (0-10µl/ml) in vitro.  
Proliferation was measured by tritiated thymidine ([3H] thymidine) 
incorporation 7 days later.  PBMCs from old and young volunteers showed 
similar maximal proliferative responses to stimulation with VZV lysate (p=0.92, 
Mann Whitney test) (Figure 3.2).    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2 PBMC proliferation in response to VZV lysate in vitro assessed by [3H] 
thymidine incorporation  
 
PBMCs from old (n=19) and young (n=19) individuals were stimulated with a range of 
VZV lysate concentrations (0-10µl/ml) in vitro, with tests performed in triplicate at 
each concentration. After 7 days, 10µl of 0.0025MBq [3H] thymidine was added and 
the samples incubated for a further 16 hours.  [3H] thymidine incorporation was 
assessed by liquid scintillation counting.  The mean cpm was calculated from the 
triplicate readings at each lysate concentration used.  The maximum mean 
proliferation value was used for analysis irrespective of the corresponding lysate 
concentration.  Graph shows cumulative data and the mean value for each group. No 
difference was detected in the maximum level of PBMC proliferation between the old 
and young volunteers (p=0.92, Mann Whitney test).   
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However, PBMCs from young individuals showed a greater proliferative 
response than the old at the lowest VZV lysate concentrations of 0.5 µl/ml 
(*p=0.04, Mann Whitney test) (Figure 3.3).  This suggests that although 
potential proliferative capacity in the old is equal to that of the young, it does 
require a higher antigen dose to achieve it.  Alternatively, it may reflect a 
lower number of initial VZV-specific T cells in the circulation.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3 PBMC proliferation assessed by [3H] thymidine incorporation in response 
to in vitro stimulation with VZV lysate at a range of concentrations  
 
PBMCs from old (n=19) and young (n=19) individuals were stimulated with a range of 
VZV lysate concentrations (0-10µl/ml) in vitro, with tests performed in triplicate at 
each concentration. Graph shows cumulative data with the mean value and SEM for 
each group at a given dose.  The young only show greater proliferation at the lowest 
dose compared to the old volunteers (*p=0.04 Mann Whitney test). 
 
 
To determine if the frequency of VZV-specific T cells was reduced in the old 
compared to the young, we assessed Ki67 expression in responding cells at 
an earlier time point after stimulation.  This also allowed us to distinguish 
between responding CD4+ and CD8+ T cells.  Freshly isolated PBMCs from 
old (n=21) and young (n=18) individuals were stimulated with VZV lysate 
(4µl/ml) in vitro and incubated for 3 days before staining for Ki67 expression. 
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No difference was found in Ki67 expression in CD4+ or CD8+ T cell subsets 
between the young and old volunteers (p=0.95 and 0.82 respectively, Mann 
Whitney test) (Figure 3.4) suggesting that the frequency of VZV-specific T 
cells is similar in the old and young.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4 PBMC proliferation assessed by Ki67 expression in response to 
stimulation with VZV lysate in vitro 
 
PBMCs from old (n=21) and young (n=18) individuals were stimulated with VZV 
lysate (4µl/ml) in vitro, incubated for 3 days and then stained for Ki67 expression. 
Samples were analysed by flow cytometry. The graph shows cumulative data and 
the mean values for each age group and subset.  There was no difference in Ki67 
expression in either CD4+ or CD8+ T cell subsets between old and young individuals 
(p=0.95 and 0.82 respectively, Mann Whitney test). 
 
 
The function of VZV specific CD4+ T cells in peripheral blood was investigated 
by their ability to produce cytokines in response to in vitro stimulation with 
VZV lysate.  Freshly isolated PBMCs from old (n=20) and young (n=20) 
individuals were stimulated with 40µl/ml VZV lysate for 15 hours in the 
presence of Brefeldin A.  Samples were stained for expression of IFN-γ and 
IL-2.  There were significantly fewer IFN-γ+CD4+ T cells identified from the old 
volunteers compared to the young (p=0.04, Mann Whitney test) (Figure 3.5).  
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Figure 3.5 Frequency of VZV specific CD4+ T cells by intracellular cytokine staining 
 
PBMCs from old (n=20) and young (n=20) individuals were stimulated with VZV 
lysate (40µl/ml) in vitro for 15 hours in the presence of Brefeldin A. Cells were 
stained for IFN-γ and IL-2 and analysed by flow cytometry.  Graph shows cumulative 
data and the mean values for each group.  The percentage of IFN-γ+CD4+ T cells 
(VZV-specific cells) was significantly lower in the old individuals compared to the 
young (*p=0.04, Mann Whitney test). IL-2+CD4+ T cells were not present in significant 
numbers compared to non-stimulated controls. 	  	  	  
Neither IL-2+CD4+ T cells, nor IFN-γ+ or IL-2+ CD8+ T cells were found in high 
enough numbers to quantitate compared to non-stimulated controls in either 
age group at the time point investigated.  IL-2 production, although low at this 
early stage, is adequate to support subsequent T cell proliferation in both the 
old and young (Figures 3.2 and 3.4).  The above results demonstrate that 
while the number of VZV specific T cells in peripheral blood appears to be 
equal in the young and old, the function of these cells assessed by cytokine 
secretion is impaired in the old volunteers, highlighted by the reduced 
proportion of IFN-γ+CD4+ T cells after stimulation in vitro in the old, confirming 
previous reports (Asanuma, Sharp et al. 2000; Patterson-Bartlett, Levin et al. 
2007). 
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3.4 Differentiation status of VZV-specific T cells in peripheral blood 
 
To further characterise the VZV-specific CD4+ T cells in the peripheral blood 
we examined their differentiation status. PBMCs were isolated from blood 
sample from old and young volunteers.  VZV-specific CD4+ T cells were 
identified by their ability to synthesise IFN-γ after overnight stimulation with 
VZV lysate as described above.  Cells were also stained for the presence of 
CD27, CD28, and CD45RA allowing examination of differentiation state.  The 
data on the elderly cohort was gathered previously by another member of our 
group, Dr Sarah Jackson (Figure 3.6).  The majority of VZV-specific T cells 
were of central memory phenotype (CD45RA-CD27+) and were not a highly 
differentiated population (CD27+CD28+) in both the young and old groups 
(Figure 3.6).   
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Figure 3.6 Differentiation state of peripheral blood VZV specific CD4+ T cells  
 
PBMCs were isolated from peripheral blood samples taken from young (n=12) and 
old (n=14) volunteers and stimulated for 15 hours with VZV lysate in the presence of 
Brefeldin A. Cells were stained for expression of IFN-γ to identify VZV specific T cells 
as well as CD27, CD28 and CD45RA, key differentiation markers. Samples were 
analysed by flow cytometry. (A, B) Graphs show cumulative data. Bars show mean 
values. Each symbol represents one individual. VZV-specific T cells show a 
predominantly central memory like phenotype (CD45RA-CD27+) in both old and 
young volunteers. The majority of VZV-specific T cells in peripheral blood are not 
highly differentiated (CD27+CD28+).   
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3.5 Discussion 
 
This work has demonstrated that the skin DTH response to VZV skin test 
antigen is reduced in old individuals compared to young and this is in keeping 
with previous work (Sadaoka, Okamoto et al. 2008).  We also confirm that the 
function of VZV–specific cells is impaired in the old individuals demonstrated 
by significantly fewer CD4+IFN-γ+ T cells after in vitro stimulation with VZV 
lysate compared to in the young (Asanuma, Sharp et al. 2000; Patterson-
Bartlett, Levin et al. 2007; Levin, Oxman et al. 2008; Sadaoka, Okamoto et al. 
2008).  However, in contrast to studies that have used responder cell 
frequency to report a reduced number of circulating VZV specific T 
lymphocytes in the elderly (Levin, Oxman et al. 2008) we found that the 
number of cells entering cell cycle soon after stimulation assessed by Ki67 
expression was similar between the two groups.  This suggests that the 
number of circulating VZV-specific cells is not different between the groups.  
Other work has shown an increase in the number of VZV-specific cells in the 
elderly (Patterson-Bartlett, Levin et al. 2007).   
 
CD4+IL-2+ VZV-specific cells were not seen in high enough numbers to 
quantitate in either age group.  IL-2 production is predominantly seen during 
activation of naïve T cells and TCM cells more so than TEM cells (Sallusto, 
Lenig et al. 1999).  IL-2 was present in the supernatant of VZV-stimulated 
blood lymphocytes from immune adults (Hayward, Cosyns et al. 1998).  Other 
studies have shown that lymphocytes from elderly individuals produce 
significantly less IL-2 after stimulation (Gillis, Kozak et al. 1981; Huang, 
Pechere et al. 1992; Rink, Cakman et al. 1998).  It is possible that increasing 
our sample size would allow us to detect such a difference between the two 
groups if it exists.  
 
VZV-specific CD8+ T cells did not produce high enough levels of either IL-2 or 
IFN-γ to be identified in this work.  The scarcity of cytokine secreting VZV-
specific CD8+ T cells has been reported in previous studies (Asanuma, Sharp 
et al. 2000; Patterson-Bartlett, Levin et al. 2007).  This remains the case even 
when a number of different VZV antigens have been used to stimulate VZV-
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specific T-cells with the majority of responses being mediated by CD4+ T cells 
(Jones, Black et al. 2006).  This relative lack of VZV-specific CD8+ T cells may 
reflect the known MHC class I down-regulation induced by VZV (Abendroth, 
Lin et al. 2001). However, CD8+IFN-γ+ cells are shown to increase in old 
individuals after receiving the shingles vaccine but returned close to baseline 
by 6 weeks after vaccination, suggesting this is a tightly regulated population 
(Patterson-Bartlett, Levin et al. 2007).  The proliferation of CD8+ T cell seen 
by Ki67 expression may reflect in part a bystander effect (Tough, Borrow et al. 
1996; Tough, Zhang et al. 2001; Koschella, Voehringer et al. 2004).  
 
We investigated the differentiation status of total and VZV-specific T cells by 
examining the expression of CD45RA, CD27 and CD28.  Previous work by 
our group has shown that subsets identified by CCR7 and CD27 were very 
similar although not completely overlapping (Libri, Azevedo et al. 2011).  We 
used CD27 in combination with CD45RA to discriminate between the T cell 
subsets: naïve (CD45RA+CD27+), central memory (CD45RA-CD27+), effector 
memory (CD45RA-CD27-) and CD45RA re-expressing effector memory cells 
(CD45RA+CD27-).  As would be expected, the old volunteers had a smaller 
naïve (CD45RA+CD27+) and larger memory population in the total T cell pool 
compared to the young.  The majority of VZV-specific cells in both old and 
young volunteers are of predominantly central memory phenotype (CD45RA-
CD27+) and are not highly differentiated (CD27+CD28+).  Large central 
memory populations of VZV-specific T cells that are not highly differentiated 
have also been identified in other studies (Patterson-Bartlett, Levin et al. 
2007; Malavige, Jones et al. 2008).  There were also significant naïve-like 
(CD45RA+CD27+) populations in the VZV-specific T cell populations in both 
young and old volunteers in keeping with the possibility that some central 
memory cells can re-express CD45RA (Geginat, Lanzavecchia et al. 2003; 
Dunne, Belaramani et al. 2005). The purpose of re-expression of CD45RA in 
such a scenario is unclear.  Given that VZV is proposed to undergo clinically 
silent reactivation relatively frequently (Quinlivan, Ayres et al. 2007; Malavige, 
Jones et al. 2008) it might be expected, contrary to our observations, that in 
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the old a greater proportion of the VZV-specific cells would be more highly 
differentiated.   
 
There are several possible reasons why VZV-specific T cells in the elderly 
may display reduced IFN-γ production e.g. effector CD4+ T cell functions may 
come under increased suppression as a result of the increased proportion of 
circulating Tregs in the elderly (Trzonkowski, Szmit et al. 2006; Vukmanovic-
Stejic, Zhang et al. 2006); raised type 1 interferon signalling in the process of 
inflamm-ageing (Giunta 2008) may suppress virus specific CD4+ T cell 
function (Wilson, Yamada et al. 2013); VZV-specific cells may be out-
competed by other memory expansions present in the old (Khan, Hislop et al. 
2004). 
 
The reduced clinical DTH response to VZV antigen in the skin of the old 
volunteers could be attributed to a reduced number of functioning VZV 
specific T cells being available for recruitment from the circulation into the 
skin.  In the next chapter we will explore this further by comparing the cellular 
infiltrate at the site of the DTH response between young and old volunteers. 
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Chapter 4:  Cellular cutaneous response to VZV antigen in old 
and young individuals 
 
4.1 Introduction 
 
 
In the last chapter we showed that old volunteers show a reduced clinical 
response to VZV antigen in the skin compared to young volunteers.  We also 
showed that this did not reflect the number of circulating VZV-specific T cells 
which were similar in the two age groups.  However, there are many other 
cells involved in the induction of a recall response in the skin, given that it is 
an integrated multistep process.  Therefore in this chapter we compared the 
kinetics of the cellular response to VZV antigen in the skin of old and young 
individuals.  We did this by taking skin biopsies at various time points after 
VZV antigen injection into the skin allowing us to study the in vivo events as 
they unfolded.  
 
4.2 Cutaneous T cell response to VZV antigen 
4.2.1 T cell accumulation at site of cutaneous VZV challenge 
 
Since DTH responses are dependent on antigen-specific CD4+ T cells we first 
investigated whether the reduced clinical response to the VZV antigen in the 
old individuals was associated with a reduced infiltration of lymphocytes.  We 
took 5mm punch biopsies of normal skin and at 1, 3 and 7 days after VZV 
antigen injection at the site of the intradermal injection, from at least 3 young 
and 3 old volunteers for each time point.  Haematoxylin and eosin staining 
(kindly performed by technician staff, Histopathology Department, Royal Free 
Hospital) of skin sections taken after VZV antigen injection from old and 
young volunteers shows the presence of large, dense predominantly 
perivascular lymphocytic infiltrates in the young individuals, and these are 
considerably larger than those seen in the old at all time points (Figure 4.1).  
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Figure 4.1 Lymphocytic infiltrate at the site of the cutaneous DTH response in old 
and young volunteers  
 
Skin sections from biopsies taken 1, 3 and 7 days after VZV antigen injection from 
old and young volunteers were stained with haematoxylin and eosin (x10).  Large 
dense predominantly perivascular lymphocytic infiltrates are seen in the young at 
days 1, 3 and 7 post VZV skin test.  Although present in the old, the perivascular 
infiltrates are considerably smaller in size. 
 
 
To characterise the infiltrate further we performed immunofluorescence 
staining to identify CD4+ and CD8+ T cell subsets.  For each section, the five 
largest perivascular infiltrates were photographed and the number of cells 
counted in each frame. The mean value of the cell count for the 5 frames was 
calculated and used for analysis.  There is an increase in the numbers of 
CD4+ T cells and CD8+ T from day 0 to day 7 in the young (p=0.0005 and 
p=0.0007 respectively, Kruskal Wallis test) but not the old (Figures 4.2 and 
4.3), with the trend visible in the young by day 1 post injection. 
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Figure 4.2 CD4+ T cell accumulation at the site of the cutaneous DTH response in 
young and old volunteers 
 
Immunofluorescence staining to identify CD4+ T cells was performed on normal skin 
sections and from biopsies taken 1, 3 and 7 days after cutaneous challenge with VZV 
antigen from old and young volunteers (n=3-7 per age group at each time point). The 
five largest perivascular infiltrates per section were photographed and counted. The 
mean of these counts was used for analysis for each individual. (A) Representative 
images are shown of CD4+ T cell infiltrates in old and young volunteers before and 
after VZV injection. (B) Graph of cumulative data and mean is shown. Each symbol 
represents one individual. CD4+ T cells numbers increase significantly over the time 
course in the young (***p=0.0005, Kruskal Wallis test) but not in the old individuals. 
There is a significant difference in the number of CD4+ T cells in the young compared 
to the old individuals by days 3 and 7 after VZV antigen injection  (*p=0.02 and 
*p=0.04 respectively, Mann Whitney test).  
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Figure 4.3 CD8+ T cell accumulation at the site of the cutaneous DTH response in 
young and old volunteers 
 
Immunofluorescence staining to identify CD8+ T cells was performed on normal skin 
sections and from biopsies taken 1, 3 and 7 days after intradermal challenge with 
VZV antigen from old and young volunteers (n=3-5 per age group at each time point). 
The five largest perivascular infiltrates per section were photographed and counted. 
The mean of these counts was used for analysis for each individual. (A) 
Representative images are shown of CD8+ T cells infiltrates in old and young 
volunteers before and after VZV injection. (B) Graph of cumulative data and mean is 
shown. Each symbol represents one individual. The number of CD8+ T cells 
increases significantly over the time course in the young (***p=0.0007, Kruskal Wallis 
test) but not in the old volunteers. There is a significant difference in the number of 
CD8+ T cells in the young compared to the old by days 3 and 7 after VZV antigen 
injection (*p=0.02 and *p=0.04 respectively, Mann Whitney test).  
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Interestingly the number of CD4+ T cells infiltrating the skin in response to 
VZV antigen is greatest at day 7 in the young cohort even though the peak 
clinical response is seen at 48-72 hours.  However, the clinical score does 
correlate with the number of infiltrating CD4+ T cells seen 3 and 7 days after 
the VZV injection (p<0.0001, linear regression analysis) (Figure 4.4).  
 	   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4 Correlation between clinical score and mean number of CD4+ T cells / PV 
infiltrate 
 
Immunofluorescence staining was performed on skin sections taken from old and 
young volunteers at days 3 and 7 after cutaneous challenge with VZV antigen to 
identify CD4+ T cells.  The five largest perivascular infiltrates per section were 
photographed and counted.  The mean of these counts was used for analysis for 
each individual.  Graph shows positive correlation between the mean number of 
CD4+T cells / PV infiltrate and clinical score (p<0.0001, linear regression analysis). 
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4.2.2 T cell proliferation at site of cutaneous VZV challenge 
 
Our group has previously shown that T cell proliferation is likely to occur in the 
skin during the Mantoux response in humans (Vukmanovic-Stejic, Reed et al. 
2006) contributing to T cell accumulation at the site of injection.  Therefore 
one factor that may contribute to the lack of T cell accumulation after VZV 
injection in the skin of the old is reduced proliferative capacity of VZV-specific 
T cells compared to the young.  We performed immunofluorescence staining 
to identify expression of Ki67 in CD4+ and CD8+ T cells on skin sections taken 
1,3 and 7 days after VZV antigen injection from old and young volunteers.  
There was significant local proliferation of CD4+ and CD8+ T cells in the young 
in the skin over the time course (***p=0.0002 and **p=0.002 respectively, 
Kruskal Wallis test) but not in the old individuals (Figure 4.5 and 4.6 
respectively).  Maximum proliferation occurred in the young at day 7 with an 
average of 20% of CD4+ T cells and 5-10% of CD8+ T cells being in cell cycle.  
Despite similar numbers of CD4+ and CD8+ T cells being present in the skin 
24 hours after the VZV skin test in both age groups, in the young there is 
subsequently significant local proliferation of these cells that is not seen in the 
elderly.  This indicates that either there is a true reduction in proliferative 
capacity of antigen-specific T cells in the skin of the elderly during the DTH 
response, or that there are inadequate numbers of antigen specific cells 
present early in the response available to undergo proliferation, possibly due 
to impaired recruitment from the circulation. 
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Figure 4.5 Proliferation of CD4+ T cells at the site of the cutaneous DTH response  
 
Immunofluorescence staining for CD4 and Ki67 expression was performed on skin 
sections from biopsies taken 1, 3, and 7 days after cutaneous challenge with VZV 
antigen from old and young volunteers (n=3-5 per age group at each time point).  
The % of double positive cells in the five largest perivascular infiltrates was 
calculated and the mean of these 5 readings was used for analysis for each 
individual. (A) Representative images are shown for day 3 and day 7 skin sections in 
old and young volunteers with cells stained for CD4 (red) and Ki67 (green). (B) 
Graph shows cumulative data and mean for each group.  Each symbol indicates one 
individual.  There is a significant increase in the mean % of CD4+Ki67+ T cells over 
the time course in the young (***0.0002, Kruskal Wallis test) but not in the old 
individuals. There are significantly more proliferating CD4+ T cells in the young cohort 
compared to the elderly, 3 and 7 days after VZV antigen injection (*p=0.02 and 
*p=0.03 respectively, Mann Whitney test).  
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Figure 4.6 Proliferation of CD8+ T cells at the site of the cutaneous DTH response 
 
Immunofluorescence staining for CD8 and Ki67 expression was performed on skin 
sections from biopsies taken 1, 3, and 7 days after cutaneous challenge with VZV 
antigen from old and young volunteers (n=3-5 per age group at each time point). The 
% of double positive cells in the five largest perivascular infiltrates was calculated 
and the mean of these 5 readings was used for analysis for each individual. (A) 
Representative images are shown for skin sections taken 3 and 7 days after VZV 
antigen injection from old and young volunteers with cells stained for CD8 (red) and 
Ki67 (green). (B) Graph shows cumulative data and the mean for each group. Each 
symbol represents one individual. There is a significant increase in the mean % of 
proliferating CD8+ T cells in young individuals over the time course (**p=0.002, 
Kruskal Wallis test) not present in the elderly.  
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4.2.3 Accumulation of CD4+Foxp3+ T cells at site of cutaneous VZV 
challenge 
 
Older individuals have an increased proportion of Tregs in normal skin (Agius, 
Lacy et al. 2009).  Tregs are known to have a suppressive effect on immune 
responses and we hypothesised that they may play a role in dampening the 
cellular response to VZV antigen in the skin of the old volunteers e.g., by 
reducing proliferation of antigen-specific T cells.  We therefore compared the 
accumulation of Tregs in the skin of old and young individuals during the DTH 
response to VZV antigen.  We performed immunofluorescence staining to 
identify CD4+ and Foxp3+ T cells on skin sections from biopsies taken 1, 3 
and 7 days after VZV antigen injection from old and young volunteers.  There 
was an increase in the mean number of CD4+Foxp3+ T cells per perivascular 
infiltrate over the time course in the young but not the old volunteers 
(p=0.0005, Kruskal Wallis test, Figure 4.7) reflecting the trend for the mean 
number of CD4+ T cells.  Therefore the proportion of CD4+Foxp3+ T cells 
remained relatively stable in both old and young volunteers over the time 
course and the proportion of CD4+Foxp3+ T cells remained significantly higher 
in the old volunteers compared to the young throughout (D1 **p=0.008, D3 
*p=0.02, D7 *p=0.02 respectively, Mann Whitney test).  
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Figure 4.7 Accumulation of CD4+Foxp3+ T cells at the site of the cutaneous DTH 
response in young and old volunteers 
 
Immunofluorescence staining for CD4 and Foxp3 expression was performed on skin 
sections from biopsies taken 1, 3 and 7 days after VZV antigen injection from old and 
young volunteers.  The % of double positive cells in the five largest perivascular 
infiltrates was calculated and the mean of these 5 readings was used for analysis for 
each individual.  (A) Representative images are shown of skin sections at each time 
point from old and young volunteers stained for CD4 (green) and Foxp3 (red).  (B) 
Graph shows mean of data for each age group at stated time points (n=3-5 per age 
group at each time point) +/- SEM.  There is a significant increase in the mean 
number of CD4+Foxp3+ T cells in perivascular infiltrates in young individuals over the 
time course (***p=0.0005, Kruskal Wallis test). Significant accumulation of 
CD4+Foxp3+ T cells is not seen in the old cohort. (C) Graph shows mean of data for 
each age group at stated time points (n=3-5 per age group at each time point) +/- 
SEM.  The mean proportion of CD4+Foxp3+ T cells remains relatively stable over the 
time course in young and old volunteers.  The mean proportion of CD4+Foxp3+ T 
cells remains significantly higher in the old compared to the young at all stated time 
points (day 1 **p=0.008, day 3 *p=0.02, day 7 *p=0.02 respectively, Mann Whitney 
test). 
 
 
To determine if the accumulation of CD4+Foxp3+ T cells at least in the young 
was due in part to local proliferation mirroring the accumulation of the total 
CD4+ T cell population, we performed immunofluorescence staining for Foxp3 
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identified by overlap of these two stains (Figure 4.8) providing evidence of 
some local proliferation of Foxp3+ T cells over the time course.  
 
B 
 
Fig 4.8 Proliferation of CD4+Foxp3+ T cells at the site of the cutaneous DTH 
response  
 
Immunofluorescence staining for Foxp3 and Ki67 expression was performed on skin 
sections from biopsies taken 1, 3, and 7 days after cutaneous challenge with VZV 
antigen in young volunteers, to identify proliferating CD4+Foxp3+ T cells. The % of 
double positive cells in the five largest perivascular infiltrates was calculated and the 
mean of these 5 readings was used for analysis for each individual (A) 
Representative images of co-staining are shown Foxp3 (red) and Ki67 (green).  (B) 
Graph shows cumulative data, mean and SEM for each group (n=3-5 per age group 
at each time point).  There is a trend for the mean % of proliferating CD4+Foxp3+ to 
increase over the time course as seen in the total CD4+ T cell population. 
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We compared normal skin from old individuals who typically mount a poor 
clinical response and young individuals who mount a robust clinical response 
and found that this disparity in the proportion of Tregs is present prior to the 
injection of the VZV antigen (**p=0.006, Mann Whitney test, Figure 4.9) 
(Agius, Lacy et al. 2009).  Interestingly when we examined the normal skin of 
a small subset of old volunteers who responded to the VZV antigen in a 
manner similar to young volunteers, the proportion of CD4+Foxp3+ T cells was 
significantly lower than in the typical old cohort (*p=0.02, Mann Whitney test) 
and more in keeping with the young cohort.  This implies indirectly that the 
resident CD4+Foxp3+ T cells may exert a negative regulatory effect on the 
subsequent evolution of the cutaneous DTH response.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 4.9 Proportion of CD4+Foxp3+ T cells in normal skin of old and young volunteers  
 
Immunofluorescence staining for CD4 and Foxp3 expression was performed on 
sections of normal skin taken from old and young volunteers.  The % of double 
positive cells in 5 fields was calculated and the mean of these 5 readings was used 
for analysis for each individual (n=5-8 for each group).  Graph shows the mean +/- 
SEM of the data for each group.  The average proportion of CD4+Foxp3+ T cells is 
significantly higher in normal skin of old people compared to young (**p=0.006 Mann 
Whitney test). The average proportion of CD4+Foxp3+ T cells in the old group was 
also significantly higher (*p=0.02, Mann Whitney test) than that seen in a small 
subset of old volunteers who mounted a strong clinical response to VZV antigen, who 
had similar proportions of CD4+Foxp3+ T cells to the young. 
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4.3 Activation of dermal endothelium at site of the DTH response  
 
We have shown above that local T cell proliferation is likely to contribute in 
part to antigen-specific T cell accumulation at the site of the DTH response in 
young individuals.  T cell accumulation was not seen in the elderly and may 
reflect an inability to recruit antigen-specific T cells from the circulation into the 
skin or inadequate activation of skin resident T cells with failure to induce 
appropriate proliferation.  Pro-inflammatory cytokines such as TNF-α and IL-1 
released during innate immune responses to infection or trauma are 
responsible for activating local endothelium.  In the skin, activated dermal 
endothelium up-regulates expression of cell-adhesion molecules E-selectin 
ICAM-1 and VCAM-1 promoting binding of circulating antigen-experienced T 
cells and other leukocytes to the site of inflammation (Groves, Allen et al. 
1995).  Skin homing memory T cells express corresponding ligands e.g., CLA, 
which binds E-selectin.  Upregulation of E-selectin expression on activated 
endothelium is seen as early as 2 hours after stimulation with cytokines 
(Wyble, Hynes et al. 1997), and precedes that of ICAM-1 and VCAM-1 
(Bevilacqua 1993).  To determine if there was a defect in activation of dermal 
endothelium in the old volunteers compared to the young after VZV antigen 
injection we performed immunofluorescence staining for CD31, a cell surface 
adhesion molecule constitutively expressed on dermal endothelium and E-
selectin.   We assessed skin sections from biopsies taken 1 and 3 days after 
VZV antigen injection from old and young volunteers.  On average, 20% of 
dermal blood vessels were activated in the old compared to approximately 
75% in the young at both 1 and 3 days after VZV antigen challenge (*p=0.016 
and 0.027 respectively, Mann Whitney test) (Figure 4.10).  Endothelial 
activation in the dermis, assessed by expression of E-selectin, is significantly 
reduced in the old compared to the young and this could impair the ability of T 
cells to migrate to the site of the DTH response. 
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Figure 4.10 Activation of dermal endothelium at site of DTH response  
 
Immunofluorescence staining for CD31 and E-selectin expression was performed on 
skin sections from biopsies taken 1 and 3 days after cutaneous challenge with VZV 
antigen from young and old volunteers (n=4-5 per age group at each time point). The 
number of double positive staining vessels expressed as a proportion of the total 
number of vessels in the superficial and mid-dermis of each section was used for 
analysis for each individual. (A) Representative images are shown of CD31 (green) 
and E-selectin (red) expression as well as merged views where overlap of the 
fluorochromes indicates activated endothelium. (B) Graph shows cumulative data 
and mean values for each group. Each symbol represents one individual.  There are 
significantly fewer activated dermal vessels in the old individuals, both 1 and 3 days 
after VZV antigen challenge, compared to in the young (*p=0.016 and *p=0.027 
respectively, Mann Whitney test). 
 
 
 
 
4.4 Accumulation of cells of innate immune system at site of the DTH             
response 
 
Cells of the innate immune response play a vital role in generating an 
adaptive immune response by virtue of functions such as pro-inflammatory 
cytokine production and antigen presentation to antigen-specific T cells.  The 
inflammatory environment is particularly important for activating endothelium 
to enhance recruitment of leukocytes from the circulation.  Accumulation of 
macrophages during the Mantoux test, a classical DTH responses has been 
well documented (Poulter, Seymour et al. 1982) and a variety of DC subsets 
are involved in cutaneous inflammation.  We therefore hypothesised that a 
difference in these populations during the DTH response between the young 
and old volunteers may be contributing to impaired dermal activation and lack 
of T cell accumulation in the elderly.  Many of the macrophage and DC 
markers overlap however it has been shown that CD163 can be used to 
selectively stain for macrophages whilst CD11c is a good selective marker for 
DCs in normal human skin (Zaba, Fuentes-Duculan et al. 2007). 
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4.4.1 Accumulation of dendritic cells at site of the DTH response 
 
Immunohistochemical staining for CD11c expression was performed on skin 
sections from biopsies of normal skin or skin taken 1, 3, or 7 days after VZV 
antigen injection from old and young volunteers.  Although similar numbers of 
CD11c+ DCs were present in normal skin of both groups, there was a 
significant increase in numbers over the time course seen in the young, but 
not in the old (**p=0.008, Kruskal Wallis test) (Figure 4.11).  By 24 hours post 
VZV antigen injection there were significantly more CD11c+ DCs present in 
the young compared to the old (*p=0.040, Mann Whitney test).  
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Figure 4.11 Accumulation of CD11c+ dendritic cells at the site of cutaneous DTH 
response 
 
Normal skin sections from old and young volunteers and those taken 1, 3 and 7 days 
after VZV antigen injection were stained for CD11c by immunohistochemistry (n=3-5 
per age group at each time point). The number of positive cells was counted per 
field.  Where more than one field was needed to assess the section, the mean 
number of cells per field was used for analysis. (A) Representative images are 
shown of old and young sections at all time points.  (B) Graph shows cumulative data 
and the mean values for each group.  Each symbol represents one individual. There 
is a significant increase in mean number of CD11c+ DCs in the young over the time 
course (**p=0.008, Kruskal Wallis test) but not in the old.  24 hours after the skin test 
there were significantly more CD11c+ DCs present in the young compared to the old 
(*p=0.040 Mann Whitney test) and this difference persisted at day 7 (*p=0.036, Mann 
Whitney test). 
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To determine whether this increase in CD11c+ DCs in the young was made up 
of resident DCs or inflammatory dendritic cells recruited from the circulation 
into the skin, double immunofluorescence staining was performed to look for 
both CD11c and BDCA-1 expression.  Resident CD11c+ DCs are BDCA-1+ 
while recruited inflammatory DCs e.g., Tip-DCs seen in psoriasis are not 
(Zaba, Krueger et al. 2009).  The majority of CD11c+ DCs in the skin in the 
young after the VZV antigen injection are CD11c+BDCA-1- suggestive of an 
influx of inflammatory dendritic cells into the skin from the circulation (Figure 
4.12).  
 
Figure 4.12 Phenotype of CD11c+ dendritic cell infiltrate in young volunteers at site of 
cutaneous DTH response  
 
Immunofluorescence staining was performed on skin sections from young volunteers 
taken 1,3 or 7 days after VZV antigen injection for expression of CD11c (green) and 
BDCA-1 (red). Representative photographs are shown for each time point after VZV 
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injection. The majority of CD11c+ dendritic cells did not co-express BDCA-1 at either 
24 hours or subsequent time points.  
 
 
To further characterise these DCs we stained skin sections from old and 
young volunteers after VZV antigen injection for expression of dendritic cell 
lysosome-associated membrane protein (DC-LAMP).  DC-LAMP is a marker 
of dendritic cell maturation and is thought to play a role in the trafficking of 
MHC-antigen complexes (de Saint-Vis, Vincent et al. 1998).  DC-LAMP 
expression increases significantly in the young over the time course (days 1 to 
3 *p=0.03, Mann Whitney test, and days 1 to 7 **p=0.007, Kruskal Wallis test) 
resulting in significantly more mature DCs in the young compared to the old 
by day 7 post VZV antigen injection (*p= 0.03, Mann Whitney test) (Figure 
4.13).  This suggests that a proportion of the DCs present underwent   
maturation in the skin in young volunteers during the DTH response.   
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Figure 4.13 DC-LAMP expression at the site of DTH response 
 
Skin sections taken 1, 3 or 7 days after VZV antigen injection from old and young 
volunteers (n=3-5 per age group at each time point) were stained for DC-LAMP 
expression by immunohistochemistry.  The number of positive cells was counted per 
field.  Where more than one field was needed to assess the section, the mean 
number of cells per field was used for analysis. (A) Representative images of DC-
LAMP expression in sections from old and young volunteers at all time points after 
VZV antigen injection are shown. (B) Graph shows cumulative data and mean for 
each group.  Each symbol represents one individual. Mean DC-LAMP expression 
significantly increases in young but not old individuals over the time course 
(**p=0.007, Kruskal Wallis test).  There is a statistically significant increase in the 
mean expression of DC-LAMP in the young cohort between days 1 and 3 (*p=0.03, 
Mann Whitney test), and a significant difference in mean expression of DC-LAMP 
between the young and old by day 7 (*p=0.03, Mann Whitney test).   
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Plasmacytoid dendritic cells (pDCs) are a type of circulating dendritic cell, 
characterised by their ability to produce high quantities of type 1 interferons 
during viral infections (Gilliet, Cao et al. 2008).  They are not found in 
significant numbers in normal skin and they do not express CD11c but do 
exclusively express BDCA-2 (Dzionek, Fuchs et al. 2000).  Since pDCs are 
known to accumulate rapidly in inflamed tissues (Nestle, Conrad et al. 2005) 
and given the viral nature of our antigen, we sought to determine whether 
there was any difference in the presence of these cells in the skin of old and 
young volunteers before or after VZV antigen injection.  pDCs were identified 
by performing immunohistochemistry for BDCA-2 expression on the relevant 
skin sections.  A small number of pDCs were seen in the skin of young 
volunteers after VZV antigen injection with an increasing trend over the time 
course but not reaching statistical significance by day 3 (p=0.056, Kruskal 
Wallis test, Figure 4.14).  Day 7 data is not shown due to an inadequate 
number (<3) of data points.  A negligible number of pDCs were seen in the 
skin of old volunteers both before and after VZV antigen injection.   
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Figure 4.14 Presence of plasmacytoid dendritic cells at the site of the DTH response 
 
Skin sections from biopsies of normal skin or 1 or 3 days after VZV antigen injection 
from old and young volunteers (n=3-4 per age group at each time point) were stained 
for BDCA-2 expression by immunohistochemistry. The number of positive cells was 
counted per field.  Where more than one field was needed to assess the section, the 
mean number of cells per field was used for analysis. (A) Representative images of 
BDCA-2 staining of sections from young and old volunteers are shown.  (B) Graph 
shows cumulative data and the mean value for each group. There is an increase in 
the mean number of PDCs seen in the young between day 0 and day 3 although this 
did not reach statistical significance (p=0.056, Kruskal Wallis test). 
 
pDCs may play a role in the DTH response to VZV antigen alongside the 
influx of the much larger CD11c+ DC population in the skin of young people.  
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4.4.2 Accumulation of macrophages at site of the DTH response 
 
Skin sections from biopsies of normal skin and at 1, 3 or 7 days after VZV 
antigen injection in old and young volunteers were stained for CD163 
expression by immunohistochemistry.  Although in normal skin and 1 day after 
VZV antigen injection, macrophage numbers were comparable in the two 
groups, there was a significant increase in the number of macrophages in the 
young volunteers over the time course not seen in the old (**p=0.006, Kruskal 
Wallis test) (Figure 4.15).  By day 3, the mean number of macrophages 
peaked in the young.  There were significantly more macrophages present in 
the skin of young volunteers compared to old at day 7 (*p=0.033, Mann 
Whitney test).  
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Figure 4.15 Accumulation of CD163+ macrophages at the site of cutaneous DTH 
response 
 
Sections of normal skin and skin taken 1,3 or 7 days post VZV antigen injection from 
old and young volunteers (n=3-6 per age group at each time point) were stained for 
CD163 expression by immunohistochemistry. The number of positive cells was 
counted per field.  Where more than one field was needed to assess the section, the 
mean number of cells per field was used for analysis. (A) Representative images of 
CD163+ cells are shown in old and young skin sections at the stated time points. (B) 
Graph shows cumulative data and the mean value for each group.  Each symbol 
represents one individual. There is a significant increase in the mean number of 
CD163+ macrophages per field infiltrating the skin in young volunteers over the time 
course (**p=0.006, Kruskal Wallis test) not evident in the old. By day 7 there are 
significantly more CD163+ macrophages present per field in the young compared to 
old skin (*p=0.033, Mann Whitney test). 
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4.5 Production of TNF-α at the site of DTH response  
 
In previous work investigating the cutaneous DTH response to C. albicans 
antigen, our group showed that decreased TNF-α production by macrophages 
was associated with a reduced delayed type hypersensitivity response in the 
elderly (Agius, Lacy et al. 2009).  In that study, in contrast to this work, there 
were similar numbers of both macrophages and DCs in young and old skin 
during the DTH response.  TNF-α, produced by macrophages and dendritic 
cells may play a pivotal role in the DTH response by activating dermal 
endothelium.  In light of there being larger numbers of both macrophages and 
CD11c+ DCs in the DTH response to VZV antigen in the young individuals 
compared to the old, we would expect there to also be more TNF-α.  
However, we were interested in confirming which of these innate cells was the 
predominant cell source for TNF-α production in the current scenario given 
the early influx of DCs.  Skin sections from biopsies taken 1 and 3 days after 
VZV skin test antigen from old and young volunteers were stained for TNF-α 
and either CD11c or CD163 expression by immunofluorescence (Figure 4.16). 
As expected, there is more TNF-α present in the skin sections from young 
skin compared to old, and staining is brightest in a perivascular distribution. 
However, it is difficult to accurately determine which cell in the perivascular 
infiltrate, T lymphocytes, macrophages or dendritic cells, is the predominant 
source of the pro-inflammatory cytokine.  
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Figure 4.16 TNFα expression at the site of DTH response  
 
Skin sections from old and young volunteers taken after VZV skin test were co-
stained by immunofluorescence for TNFα and either CD11c or CD163 expression.  
(A) Representative images of a skin section from an old and young volunteer taken 1 
day after VZV antigen injection stained for CD11c (red) and TNFα (green) 
expression. (B) Representative images of old and young skin sections taken at 1 and 
3 days after VZV antigen injection, showing CD163 (red) and TNFα (green) 
expression.   
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4.6 Early events at the site of the DTH response 
 
 
The DTH response is an antigen-specific memory T cell response and we 
have shown that the function of circulating antigen-specific T cells in response 
to in vitro stimulation, as well as the in vivo accumulation of antigen-specific T 
cells at the site of the DTH response is impaired in the elderly.  There is also 
reduced accumulation of dendritic cells and reduced activation of dermal 
endothelium at 24 hours in the elderly and these factors could hinder 
recruitment of circulating leukocytes.  Next we investigated whether 
differences in the DTH response between the two age groups were apparent 
even before 24 hours.  Specifically we investigated activation of dermal 
endothelium, neutrophil infiltration, and CD4+ T cell and dendritic cell 
accumulation 6 hours after VZV antigen injection.  For these experiments, 
volunteers were also injected with normal saline intra-dermally on the 
contralateral arm to provide an internal control for changes related to trauma 
of the injection alone.  
 
4.6.1 Activation of dermal endothelium early in the DTH response  
 
We stained skin sections from biopsies taken from old and young volunteers 6 
hours after intradermal VZV antigen injection in one forearm and normal 
saline injection in the other for expression of CD31 and E-selectin by 
immunofluorescence.  There was no significant difference in the expression of 
E-selectin 6 hours after either VZV or normal saline injection between old and 
young individuals with approximately 25-30% of vessels expressing E-selectin 
(Figure 4.17).  This suggests that there is a defect in the subsequent ability to 
amplify this level of activation during an antigen specific response in the 
elderly compared to that seen in young individuals at 24 hours where 
approximately 75% of dermal vessels are activated (Figure 4.10).  
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Figure 4.17 Activation of dermal endothelium early in cutaneous DTH response  
 
Skin sections from biopsies taken 6 hours after intradermal injection of 0.02ml of VZV 
antigen into one proximal forearm and 0.02ml of normal saline injection into the other 
from old (n=5) and young (n=5) volunteers were stained for CD31 and E-selectin 
expression by immunofluorescence.  The percentage of double staining vessels in 
the superficial and mid-dermis were counted per section for each individual and used 
for analysis. (A) Representative images of VZV injected skin are shown for old and 
young volunteers: CD31 (green), E-selectin (red), with overlapping images showing 
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activated endothelium. (B) Graph shows mean and standard deviation of cumulative 
data for each group.  No significant difference was found in the expression of  
E-selectin between the age groups following either VZV antigen or normal saline 
injection (Mann Whitney and Wilcoxon tests). 
 
4.6.2 Accumulation of neutrophils early in the DTH response 
 
Neutrophils are typically the first leukocyte population recruited from the 
circulation into inflamed tissue under the influence of chemokines and 
activated endothelium.  Given that dermal endothelium is equally activated in 
old and young volunteers early in the DTH response (6 hours post VZV 
antigen injection) we hypothesised that neutrophils should accumulate equally 
in the old and young.  To determine whether neutrophil recruitment was 
impaired, we stained skin sections from biopsies taken from old and young 
volunteers 6 hours after intradermal VZV antigen injection in one forearm and 
normal saline injection in the other for expression of neutrophil elastase 
expression by immunohistochemistry.  Similar numbers of neutrophils were 
recruited to the DTH site in old and young individuals 6 hours after VZV 
antigen and normal saline injection (Figure 4.18).  
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Figure 4.18 Accumulation of neutrophils early in cutaneous DTH response  
 
Skin sections from biopsies taken 6 hours after intradermal injection of 0.02ml of VZV 
antigen into one proximal formarm and 0.02ml of normal saline injection into the 
other from old (n=5) and young (n=5) volunteers were stained for neutrophil elastase 
expression by immunohistochemistry. (A) Representative images of staining for 
neutrophil elastase expression in VZV injected skin are shown for old and young 
volunteers. (B) Graph shows mean of cumulative data and standard deviation for 
each group.  No difference in the number of infiltrating neutrophils between old and 
young volunteers in skin injected with either VZV antigen or normal saline was found 
(Mann Whitney and Wilcoxon tests).	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4.6.3 CD4+ T cell accumulation early in the DTH response 
 
To determine whether CD4+ T cell accumulation is evident as early as 6 hours 
after antigen challenge, we stained normal skin sections and sections from old 
and young volunteers 6 hours after intradermal VZV skin test injection in one 
forearm and normal saline injection in the other for CD4 expression by 
immunohistochemistry.  There was no significant difference in the numbers of 
CD4+ T cells present in normal or injected skin between the two age groups 
(Figure 4.19).  We were not able to detect a statistically significant increase in 
the number of CD4+ T cells over the 6 hours in the young volunteers. 
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Figure 4.19 Accumulation of CD4+ T cells early in cutaneous DTH response  
 
Skin sections from biopsies of normal skin and from skin taken 6 hours after 
intradermal injection of 0.02ml of VZV antigen into one proximal formarm and 0.02ml 
of normal saline injection into the other from old (n=5) and young (n=5) volunteers 
were stained for CD4 expression by immunohistochemistry. (A) Representative 
images of staining for CD4 expression in VZV injected skin are shown for old and 
young volunteers. (B) Graph shows mean of cumulative data and standard deviation 
for each group.  No statistically significant difference in the number of infiltrating 
CD4+ T cells was found between old and young volunteers in normal or injected skin, 
nor was there a significant increase in numbers between baseline and 6 hours after 
injection in either age group (Mann Whitney and Wilcoxon tests).	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4.6.4 Accumulation of dendritic cells early in the DTH response 
 
We have shown that the number of CD11c+ dendritic cells in the skin 
significantly increases in young compared to old volunteers by 24 hours after 
VZV antigen injection.  To determine if this trend can be detected early in the 
DTH response, we stained skin sections from old and young volunteers 6 
hours after intradermal VZV skin test injection in one forearm and normal 
saline injection in the other for CD11c expression by immunohistochemistry.  
Six hours after VZV skin test antigen injection the number of CD11c+ dendritic 
cells increases significantly in the young (*p=0.03, Mann Whitney test) (Figure 
4.20).  Despite this there is no statistically significant difference in the number 
of CD11c+ DCs between the young and old 6 hours after VZV injection and 
this only becomes evident at 24 hours (Figure 4.11).  However, in the majority 
of old volunteers (n=4 out of 5) the number of CD11c+ cells is lower than that 
seen in the young 6 hours after injection with VZV antigen suggestive of a 
trend.  The number of CD11c+ cells present 6 hours after injection with normal 
saline was not significantly different from those seen after VZV antigen 
injection.  The sections were also stained for expression of Ki67 and CD11c 
by immunofluorescence but cells co-expressing the markers, indicative of 
local proliferation, were rare in both age groups.  While some of the dendritic 
cells may have migrated from distal parts of the skin to the site of antigen 
challenge, our data supports an influx of dendritic cells in the young from the 
circulation (Figure 4.12). 
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Figure 4.20 CD11c+ dendritic cell presence early in cutaneous DTH response  
 
Skin sections from biopsies taken of normal skin from old (n=5) and young (n=4) 
volunteers, and 6 hours after intradermal injection of 0.02ml of VZV antigen into one 
proximal forearm and 0.02ml of normal saline into the other from old (n=5) and young 
(n=5) volunteers were stained for CD11c+ expression by immunohistochemistry. (A) 
Representative images of staining for CD11c expression in VZV injected skin are 
shown for old and young volunteers. (B) Graph shows mean of cumulative data and 
standard deviation for each group.  There is a significant increase in the number of 
infiltrating CD11c+ cells in the young 6 hours after the injection of VZV (*p=0.03 
Mann-Whitney test) but not in the old (p=0.67 Mann-Whitney test) nor in either age 
group after injection with normal saline.  There was no significant difference in the 
number of CD11c+ cells between young and old in either normal skin or after normal 
saline or VZV injection  (Mann Whitney test).  Nor was there any difference in the 
number of CD11c+ cells present within the same age group after VZV or normal 
saline injection (Wilcoxon matched-pairs test). 	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4.7 Discussion 
 
 
In this chapter we report that that old individuals have an impaired cutaneous 
DTH response to VZV antigen manifest by an absence of the T cell 
accumulation that occurs in the young.  Old and young individuals have 
similar numbers of T cells in normal skin however the trend for a subsequent 
increase in number is evident by 24 hours after VZV injection in young 
individuals only.  By day 3 the number of T cells is significantly higher in the 
young compared to the old individuals with the greatest number of T cells 
seen at day 7.  This accumulation is in part due to local proliferation of T cells 
in the skin.  Interestingly the peak in T cell accumulation occurs after the peak 
clinical response rather than coinciding with it.  However, the clinical score 
does correlate with the number of infiltrating T cells suggesting that the early 
inflammatory response is crucial to the development of subsequent T cell 
accumulation.   
 
It is possible that in the elderly the lack of T cell accumulation reflects a 
reduced ability of antigen specific T cells to migrate into or proliferate in the 
skin in response to antigen.  However, we propose that the impaired T cell 
response may reflect a failure of other cells present in the skin e.g., dendritic 
cells, macrophages or resident T cells to condition the cutaneous environment 
adequately to allow T cell recruitment and/or proliferation.  
 
Cells resident in normal skin are required to initiate the DTH response and an 
early feature of inflammation is activation of the dermal endothelium.  
Activated endothelium up regulates expression of adhesion molecules such 
as E-selectin, ICAM-1 and VCAM-1 to recruit circulating leukocytes including 
T lymphocytes (Bevilacqua 1993).    Previous work has shown that expression 
of E-selectin was reduced in cutaneous squamous cell carcinomas and that 
these contained few CLA+ T cells.  Treatment with imiquimod, a TLR 7 
agonist, up-regulated E-selectin expression and was associated with an influx 
of CLA+ T cells (Clark, Huang et al. 2008).  We found that in the elderly 
despite similar low-level expression of E-selectin at 6 hours in both groups 
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after either VZV antigen or normal saline injection, there is a subsequent 
failure to amplify this in the elderly after VZV antigen injection.  Twenty-four 
hours after VZV injection, 70% of dermal vessels express E-selectin in the 
young individuals but only 30% of vessels do so in the elderly and this may 
contribute to reduced recruitment of T cells in the old. It would be of interest to 
investigate the expression of other adhesion molecules such as ICAM-1 and 
VCAM-1 to see if they are similarly reduced in the elderly, as was shown in 
the DTH response to Candida albicans (Agius, Lacy et al. 2009). 
 
Pro-inflammatory cytokines such as TNF-α, IFN-γ and IL-1α are known to 
activate dermal endothelium (Lee, Chung et al. 1995).  Dendritic cells, 
macrophages and CD4+ TH1 cells may act as early producers of these 
cytokines.  Therefore it may be that these skin resident innate cells are 
defective in the elderly.  Alternatively tissue resident antigen specific T cell 
populations have recently been identified (Gebhardt, Whitney et al. 2011; 
Teijaro, Turner et al. 2011; Jiang, Clark et al. 2012) and it may be that VZV-
specific T cells present in the skin may be reduced in number or function in 
the elderly with reduced production of pro-inflammatory cytokines from these 
cells.  Of note, while TNF-α and IL-1α induced expression of E-selectin peaks 
after 6 hours, IFN-γ induced expression of E-selectin on dermal endothelium 
is not detectable until 24 hours and peaks at 48 hours (Lee, Chung et al. 
1995).  Alternatively or in addition to the above, the function of any of these 
skin resident populations may be suppressed by skin resident Tregs 
(Takahashi, Kuniyasu et al. 1998).  Clinically Tregs in squamous cell 
carcinomas of the skin can make up 50% of the infiltrating T cell population 
and effective treatment is associated with both reducing Treg number and 
function (Clark, Huang et al. 2008).  In support of a prominent role for Tregs in 
influencing T cell accumulation, we found that Tregs are present in greater 
proportions in elderly individuals with impaired DTH responses compared to 
both young individuals and the small number of elderly volunteers who 
maintain relatively robust clinical responses.  
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In addition to T cells, other circulating populations are also recruited to the 
skin during a DTH response including neutrophils, DCs and macrophages.  
Recruitment of these cells may be affected by an inadequate production of 
pro-inflammatory cytokines or chemokines early in the DTH response, and/or 
these recruited populations may influence subsequent T cell recruitment. 
Neutrophils are typically the first leukocytes to be recruited during an 
inflammatory response and were present in similar numbers in the skin of 
both old and young individuals 6 hours after VZV antigen or normal saline 
injection.  This is likely to represent an antigen non-specific response and is 
seen after needle-induced tissue damage (Peters, Egen et al. 2008).  
Although there is evidence that particular neutrophils subsets are able to 
influence the subsequent immune response (Tsuda, Takahashi et al. 2004), 
murine studies where neutrophils have been depleted demonstrate that while 
the acute phase of the DTH response is suppressed, late phase T cell 
infiltration is not significantly affected (Hwang, Yamanouchi et al. 2004; 
Doebis, Siegmund et al. 2008).   
 
Six hours after VZV antigen injection we found that CD11c+ dermal dendritic 
cells start to accumulate in the young but not the elderly.  This accumulation is 
not seen after injection of normal saline in young individuals suggesting that it 
is an antigen specific response.  The number of CD11c+ DCs is significantly 
greater in the young individuals than in the old by 24 hours.  The lack of 
BDCA-1 and Ki67 expression on the majority of these cells leads us to 
conclude that these are most likely a recruited population from the circulation.  
The increase in expression of DC-LAMP between day 1 and day 3 suggests 
these DCs are undergoing maturation in the skin (de Saint-Vis, Vincent et al. 
1998).  In this state they would be ready to activate antigen specific T cells in 
the skin and contribute to amplifying the specific immune response.  A recent 
study in humans has shown that the level of DC recruitment correlated with 
the frequencies of T cells infiltrating the DTH site (Liang, Bond et al. 2013).  
However, It is not clear in our work whether the DCs recruited in the early 
phase of the response influence early T cell recruitment, or whether both 
populations are responding to antigen specific signals from skin resident cells.     
	  	  	  
	   121	  
 
Little is known about recruitment of inflammatory DC populations into the skin, 
but is likely to involve specific chemokines.  A DC-specific C-type lectin, DC-
SIGN interacts with ICAM-2 to mediate chemokine-induced migration across 
both resting and activated endothelium (Geijtenbeek, Krooshoop et al. 2000) 
and it would be of interest to compare expression of DC-SIGN on circulating 
DC populations in old and young individuals.  Although E-selectin may also 
mediate DC migration along activated endothelium (Srinivas, Larsson et al. 
1993), there was no difference in expression of E-selectin between the young 
and the elderly at the time of earliest DC recruitment in the young to account 
for the difference.  
 
Macrophages are also present in normal skin and like DCs, are early 
producers of pro-inflammatory cytokines and upon activation may present 
antigen to CD4+ T cells.  There is a similar number of macrophages present in 
the normal skin of young and old individuals.  An increase in the number of 
macrophages is seen 48 hours after VZV antigen injection but only in young 
individuals.  At this late time point, these recruited cells are unlikely to play a 
significant role in influencing the early antigen-specific response although they 
may subsequently contribute to amplification of the antigen-specific T cell 
response.  However, as mentioned above there may be an age-related defect 
in the function of those macrophages present in normal skin required to 
initiate the memory response, reduced activation of macrophages, or 
increased suppression by Tregs in the elderly. 
 
We propose that the main reason for the reduced accumulation of T cells in 
the elderly in response to VZV antigen is inadequate conditioning of the 
cutaneous environment to support recruitment of antigen-specific T cells.  
This may be as a result of a reduced number of functioning resident antigen-
specific T cells and/or innate cells which fail to stimulate an adequate early 
immune response.  The increased proportion of Tregs in the skin of the 
elderly prior to antigen challenge is in keeping with an increased potential to 
suppress local T cell responses.   
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In the young individuals we found that CD4+Foxp3+ cells accumulate over the 
time course after VZV injection in line with the corresponding CD4+ effector T 
cell population presumably to regulate the immune response.  We 
hypothesised that these two populations would share antigen specificity and 
went on to investigate this in the next chapter.     
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Chapter 5:  Detection of VZV-specific CD4+ T cells and 
characterisation of CD4+Foxp3+ regulatory T cells that 
accumulate during the cellular response to VZV antigen in the 
skin  	  
5.1 Introduction 
 
 
In the last chapter we identified that CD4+ and CD4+Foxp3+ T cells 
accumulate at the site of antigen challenge in the young.  We also showed 
that the proportion of Tregs typically increases in the skin with age and that 
this is associated with a reduced clinical and effector T cell response to VZV 
antigen injection in old volunteers.  In this chapter we investigate whether the 
CD4+ T cells seen in the skin after VZV antigen challenge are specific for 
VZV.  We also further characterise the CD4+Foxp3+ T cells to determine 
whether they are consistent with Tregs and share antigen specificity with the 
effector T cell population i.e. VZV-specific Tregs.  Tregs are a heterogenous 
population made up of nTregs, produced by the thymus, and iTregs, which 
may arise extrathymically from naïve (Azukizawa, Dohler et al. 2011; Zhou, 
Horai et al. 2012) or memory T cells (Walker, Carson et al. 2005; 
Vukmanovic-Stejic, Agius et al. 2008; Huang, Dawicki et al. 2010; Schwele, 
Fischer et al. 2012). .   
 
To further characterise the leucocytes involved in the recall response to VZV 
antigen in the skin, we induced suction blisters over the site of antigen 
injection from which leucocytes were subsequently isolated and analysed for 
markers of interest by flow cytometry (Akbar, Reed et al. 2013).  In particular 
we used a flurochrome-conjugated peptide-MHC tetramer to identify VZV-
specific T-cells, within both effector and Treg subsets.  Peptide-MHC class II 
tetramers display an antigenic peptide in the class II-binding groove and in 
this way act as a surrogate for the interaction that occurs between APCs and 
antigen specific T cells (Nepom 2012).  The tetramer was used to detect 
intermediate early 63 (IE63) - specific CD4+ T cells.  IE63 is a viral tegument 
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protein (Kinchington, Bookey et al. 1995) expressed during active VZV 
infection in the skin (Debrus, Sadzot-Delvaux et al. 1995; Nikkels, Debrus et 
al. 1995) and is present in ganglionic neurons during latency (Mahalingam, 
Wellish et al. 1996).  Since old volunteers did not mount a significant clinical 
response to VZV injection, this work was performed in young volunteers in 
whom, although the Treg population as a proportion of total CD4+ T cells was 
smaller, the actual number was higher, and therefore more suitable for further 
study. 
 
5.2 Accumulation of VZV-specific CD4+ T cells in the skin after VZV 
antigen injection  
 
To identify VZV specific CD4+ T cells we first induced a DTH response in 
young volunteers with a history of chickenpox by injecting 0.02ml VZV antigen 
intra-dermally into the medial aspect of the proximal forearm.  Six days after 
the initial injection, we raised a skin suction blister over the site of the clinical 
response.  The following day i.e. 7 days after VZV injection, coinciding with 
the peak cellular infiltrate (Figure 4.2), blister fluid was aspirated and a 
peripheral blood sample was taken from the volunteer.  Blister cells and 
PBMCs were used for subsequent experiments.  VZV-specific CD4+ T cells 
were identified using either an HLA-DRB1*1501 restricted IE63 tetramer or by 
their ability to synthesise IFN-γ or IL-2 after overnight in vitro re-stimulation 
with VZV lysate.  
5.2.1 Assessment of the frequency of VZV specific CD4+ T cells by 
intracellular cytokine staining  
 
PBMCs and blister cells were isolated 7 days after cutaneous VZV antigen 
injection and stimulated for 15 hours with VZV lysate in the presence of 
Brefeldin A.  Non-stimulated controls were also set up providing there was 
adequate numbers of blister cells isolated from the blister fluid.  Cells were 
stained for the intracellular expression of IFN-γ or IL-2 and analysed by flow 
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cytometry.  We found a significantly higher proportion of IFN-γ+ CD4+ VZV-
specific T cells and IL-2+ CD4+ VZV-specific T cells present in blister fluid 
compared to peripheral blood (***p=0.0002 and **0.008 respectively, 
Wilcoxon paired test) (Figure 5.1A, B).  While there were negligible IFN-γ+  or 
IL-2+ VZV-specific CD4+ T cells in the non-stimulated peripheral blood 
sample, significantly higher levels were produced in the non re-stimulated 
blister sample, most probably reflecting cytokine production by VZV specific 
CD4+ T cells that were activated in situ in the skin in response to the VZV 
antigen injection (*p=0.014 pooled data for IFN-γ and IL-2, Wilcoxon paired 
test).  A large proportion of VZV specific CD4+ T cells produced both IFN-γ 
and IL-2 (mean 44.3%) (Figure 5.1C).  
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Figure 5.1 Identification of VZV specific CD4+ T cells at site of cutaneous DTH 
response by intracellular cytokine staining  
 
Skin suction blisters were raised in young volunteers 7 days after cutaneous VZV 
antigen injection. PBMCs and blister cells were isolated and re-stimulated for 15 
hours with VZV lysate in the presence of Brefeldin A and stained for intracellular 
expression of IFN-γ (n=15) or IL-2 (n=8).  Graphs show cumulative data and the 
mean value for each group.  Each symbol represents one individual. (A) The re-
stimulated blister cells contained significantly more CD4+IFN-γ+ antigen-specific T 
cells compared to peripheral blood (***p=0.0002, Wilcoxon paired test). There was 
significantly more CD4+IFN-γ+ VZV specific cells in the re-stimulated blister and blood 
samples compared to the non-stimulated controls (*p=0.016 and ***p=0.0001 
respectively, Wilcoxon paired test). Representative FACS plots are shown on the left. 
(B) The re-stimulated blister cells also contained significantly more CD4+IL-2+ 
antigen-specific T cells compared to peripheral blood (**p=0.008, Wilcoxon paired 
test) and compared to the non-re-stimulated blister fluid sample (*p=0.016, Mann 
Whitney test). Representative FACS plots are shown on the left. (C) A large 
proportion of antigen specific T cells secreted both cytokines.  Graph shows mean +/- 
standard deviation (mean 44.3% +/-17.7 S.D). Representative FACS plots are shown 
on the left. 
 
5.2.2 Assessment of the frequency of VZV specific CD4+ T cells using a 
MHC class II tetramer 
 
PBMCs and blister cells were isolated 7 days after cutaneous VZV antigen 
injection in individuals known to be positive for HLA-DRB1*1501.  Cells were 
stained with an HLA-DRB1*1501 restricted IE63 tetramer and analysed by 
flow cytometry.  A higher proportion of tetramer+CD4+ T cells were identified in 
the blister cell population compared to peripheral blood (***p=0.0002, 
Wilcoxon paired test) (Figure 5.2A).  Specificity of the tetramer was confirmed 
by showing a lack of staining with a control tetramer (CLIP) in HLA-
DRB1*1501 positive individuals (n=3) and by a lack of HLA-DRB1*1501 
restricted IE63 tetramer staining in HLA-DRB1*1501 negative individuals 
(n=2) (Figure 5.2C,D).  
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Figure 5.2 Identification of VZV specific CD4+ T cells at site of cutaneous DTH 
response by class II tetramer 
 
Skin suction blisters were raised in young volunteers (n=13) who were known to be 
HLA-DRB1*1501 positive 7 days after cutaneous VZV antigen injection.  PBMCs and 
blister cells were isolated and stained with HLA-DRB1*1501 restricted IE63 tetramer.  
(A) Graph shows cumulative data and the mean value for each group. Each symbol 
represents one individual. The percentage of tetramer+CD4+ T cells in the blister fluid 
was significantly increased compared to peripheral blood (***p=0.0002, Wilcoxon 
paired test). A representative FACS plot is shown on the left.  (B) Skin suction 
blisters were raised in HLA-DRB1*1501 positive individuals (n=3) 7 days after 
cutaneous VZV antigen injection. PBMCs and blister cells were isolated and stained 
with the HLA-DRB1*1501 restricted IE63 tetramer (right panels) and with the control 
tetramer (CLIP) (left panels).  A representative dot plot is shown.  (C) Skin suction 
blisters were raised in HLA-DRB1*1501 negative individuals (n=2).  PBMCs and 
blister cells were isolated and stained as above with the HLA-DRB1*1501 restricted 
IE63 tetramer (right panels) and the control tetramer (CLIP) (left panel).  A 
representative dot plot is shown.  
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5.3 Differentiation status of VZV-specific T cells at site of the DTH 
response 
 
To further characterise the VZV-specific CD4+ T cells in the skin during the 
DTH response we examined their differentiation status. Blisters cells were 
retrieved from skin suction blisters 7 days after cutaneous VZV antigen 
injection in young volunteers.  VZV-specific CD4+ T cells were identified by 
their ability to synthesise IFN-γ or IL-2 after overnight re-stimulation with VZV 
lysate as described above and cells were stained for the presence of CD27, 
CD28, and CD45RA.  The majority of VZV-specific T cells isolated from the 
skin were of central memory and effector memory phenotype (CD45RA-
CD27+ and CD45RA-CD27- respectively) and were not highly differentiated 
(CD27+CD28+) (Figure 5.3).  
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Figure 5.3 Differentiation state of VZV specific CD4+ T cells at site of cutaneous DTH 
response 
 
Skin suction blisters were induced in young volunteers 7 days after cutaneous VZV 
antigen injection.  Blister cells were isolated and re-stimulated with VZV lysate for 15 
hours in the presence of Brefeldin A.  Cells were stained for expression of IFN-γ 
(n=12) and IL-2 (n=7) to identify VZV-specific T cell populations as well as CD27, 
CD28 and CD45RA, key differentiation markers. Samples were analysed by flow 
cytometry.  (A, B) Graphs show cumulative data.  Bars show mean values. Each 
symbol represents one individual. The majority of cells in both the total CD4+ T cell 
and CD4+ VZV-specific T cell (either IFN-γ+ or IL-2+) populations are of central 
memory and effector memory phenotype (CD45RA-CD27+ and CD45RA-CD27- 
respectively) (A) and are not highly differentiated (CD27+CD28+) (B).  
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5.4 VZV-specific memory CD4+ T cells proliferate at the site of the DTH 
response 
 
The accumulation of VZV-specific T cells seen in the skin after cutaneous 
VZV antigen injection may be the result of recruitment from the circulation and 
/ or local proliferation of recruited or resident VZV-specific T cells in the skin.  
We have already shown in chapter 4 in skin biopsies taken from young 
volunteers after VZV skin test that approximately 10-35% of CD4+T cells are 
proliferating at the site of the cutaneous DTH response by day 7 (Figure 4.5).  
To confirm that it is VZV-specific CD4+ T cells that are proliferating and 
contributing to the accumulation of T cells in the skin in response to the VZV 
skin test, we raised day 7 skin suction blisters after cutaneous VZV antigen 
injection in young (n=4) volunteers, all of whom were known to be HLA-
DRB1*1501 positive.  Blister cells were stained with HLA-DRB1*1501 
restricted IE63 tetramer and for the expression of Ki67 and analysed by flow 
cytometry.  Proliferation was seen in both tetramer positive and negative 
CD4+ T cells in the skin.  On average approximately 45% of tetramer positive 
CD4+ T cells were in cell cycle compared to approximately 20% of the 
tetramer negative CD4+ T cells (*p=0.02, paired t-test) (Figure 5.4).  This 
suggests that local proliferation of VZV-specific CD4+ T cells does occur in the 
skin.  The proliferating tetramer negative T cells would be consistent with 
activated VZV-specific CD4+ T cells present in the skin after VZV skin test that 
are responding to VZV peptides other than the immunodominant IE63 
peptide.  The proliferation rate would be expected to be lower in this tetramer 
negative population compared to the tetramer positive population due to the 
presence of non-VZV specific cells.   
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Figure 5.4 VZV specific memory CD4+ T cells proliferate at the site of the cutaneous 
DTH response 
 
We raised skin suction blisters in young volunteers (n=4), known to be HLA-
DRB1*1501 positive, 7 days after cutaneous VZV antigen injection.  Blister cells were 
stained with HLA-DRB1*1501 restricted IE63 tetramer and for the expression of Ki67.  
Samples were analysed by flow cytometry.  (A) The dot plot shows tetramer staining 
of blister cells.  The histograms show Ki67 staining of the tetramer gated populations.  
(B) Graph shows cumulative data and the mean for each group.  Each symbol 
represents one individual. Tetramer positive CD4+ T cells showed a significantly 
higher proliferative rate that the tetramer negative CD4+ T cell population (*p=0.02, 
paired t-test).   
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5.5 CD4+Foxp3+ T cells accumulate in the skin after VZV antigen 
injection and are suggestive of T regulatory cells  
 
We have already shown in chapter 4 in skin biopsies taken from young 
volunteers after cutaneous VZV antigen challenge that CD4+Foxp3+ T cells 
accumulate at the site of the DTH response alongside the memory CD4+ T 
cell response (Figure 4.7).  Activated CD4+ T cells can transiently up-regulate 
expression of Foxp3, however these cells do not express the typical Treg 
phenotype CD25hiCD127loCD39hi.  Conversely, Tregs do not secrete pro-
inflammatory cytokines after activation.  Our group has previously shown that 
CD4+Foxp3+ T cells isolated from the skin during a DTH response to PPD are 
consistent with a predominantly T regulatory rather than recently activated T 
cell population (Vukmanovic-Stejic, Agius et al. 2008).  We investigated 
whether our cutaneous CD4+Foxp3+ T cells generated during the DTH 
response to VZV antigen were also in keeping with a T regulatory population. 
 
In order to characterize the phenotype of the CD4+Foxp3+ T cells that 
accumulated in the skin after cutaneous VZV skin injection, we raised skin 
suction blisters in young volunteers 7 days after cutaneous VZV antigen 
injection. A peripheral blood sample was also taken at the time of blister 
retrieval.  Blister cells and PBMCs were isolated and stained for Foxp3, CD25, 
CD127 and CD39 expression.  Samples were analyzed by flow cytometry. 
There were significantly more CD4+Foxp3+ T cells present in the skin at the 
site of the DTH response than in peripheral blood (****p<0.0001, Wilcoxen 
paired test) (Figure 5.5).  
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Figure 5.5 CD4+Foxp3+ T cells at site of cutaneous DTH response  
 
Skin suction blisters were raised in young volunteers (n=20) 7 days after cutaneous 
VZV antigen injection.  Blister cells and PBMCs were isolated and stained for Foxp3 
expression and analysed by flow cytometry.  Each symbol represents one individual.  
Mean is shown for each group. There was a significantly larger proportion of 
CD4+Foxp3+ T cells present in the blister fluid than in peripheral blood (****p<0.0001, 
Wilcoxon paired test). 
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We found that on average more than 80% of CD4+Foxp3+ blister cells 
expressed high levels of CD25 and high levels of CD39, and that fewer than 
10% expressed high levels of CD127; this was significantly different from the 
CD4+Foxp3- population (****p<0.0001, **p=0.002, ****p<0.0001 respectively, 
Wilcoxon paired test) (Figure 5.6).  Therefore the majority of CD4+Foxp3+ T 
cells at the site of the DTH response express a typical T regulatory cell 
phenotype. 
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Figure 5.6 Phenotype of CD4+Foxp3+ T cells at site of cutaneous DTH response  
 
Skin suction blisters were raised in young volunteers 7 days after cutaneous VZV 
antigen injection.  Blister cells were isolated and stained for expression of Foxp3, 
CD25, CD127 and CD39.  Samples were analysed by flow cytometry.  (A) The dot 
plot shows gating strategy to identify CD4+Foxp3+ and CD4+Foxp3- cells (left panel).  
The histograms show representative expression of CD25, CD39 and CD127 on the 
gated populations.  (B) Graphs show cumulative data and the mean value for each 
group. Each symbol represents one individual.  CD4+Foxp3+ cells expressed 
significantly higher levels of CD25 and CD39 and significantly lower levels of CD127 
(****p<0.0001, **p=0.002, ****p<0.0001 respectively, Wilcoxon paired test) compared 
to the CD4+Foxp3- population.  
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One of the hallmarks of T regulatory cells is that they do not secrete pro-
inflammatory cytokines after stimulation.  To see if this was true of our 
CD4+Foxp3+ T cells, we isolated blister cells from skin suction blisters raised 
in young volunteers 7 days after cutaneous VZV antigen injection and 
stimulated them in vitro with VZV lysate for 15 hours in the presence of 
Brefeldin A.  Cells were stained for intracellular cytokine production (IFN-γ, 
TNF-α, IL-2 and IL-10) and analyzed by flow cytometry.  The CD4+Foxp3+ T 
cells produced much less IFN-γ and TNF-α, compared to the CD4+ T cell 
population and virtually no IL-2.  The greatest production of inflammatory 
cytokine was seen from the CD4+Foxp3-CD127lo population that represents 
the effector memory population (Sauce, Larsen et al. 2007) (Figure 5.7).  The 
lack of inflammatory cytokine production after stimulation suggests that our 
CD4+Foxp3+ T cells are functionally consistent with T regulatory cells.  
Although some T regulatory cells are able to produce IL-10, a suppressive 
cytokine, we did not see any significant production from our CD4+Foxp3+ T 
cell population.   
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Figure 5.7 Lack of pro-inflammatory cytokine production by CD4+Foxp3+ T cells at 
the site of cutaneous DTH response  
 
Skin suction blisters were raised in young volunteers 7 days after cutaneous VZV 
antigen injection.  Blister cells were isolated and stimulated with VZV lysate for 15 
hours in the presence of Brefeldin A.  Non-stimulated controls were set up in parallel. 
Cells were stained for expression of Foxp3, CD127, IFN-γ, TNF-α, IL-2 and IL-10. 
Samples were analyzed by flow cytometry.  (A) Dot plot shows gating strategy to 
identify different Foxp3 and CD127 populations from total CD4+ T cells. Cytokine 
production is shown in representative dot plots for these subsets.  
 
To determine whether our CD4+Foxp3+ population exerted a suppressive 
effect in vivo we compared the proportion of CD4+ cells expressing Foxp3+ 
cells present at the peak of the cellular response (day 7) after VZV injection 
(Figure 4.7) with the clinical score (Figure 4.1).  We found an inverse 
correlation between the proportion of CD4+Foxp3+ T cells and the clinical 
score, indirectly suggesting a suppressive role of the CD4+Foxp3+T cells 
population in vivo (p=<0.0001, linear regression analysis) (Figure 5.8).  
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Figure 5.8 Correlation of proportion of Foxp3+ expressing CD4+ cells at the peak of 
the cellular response to VZV skin test antigen and clinical score 
 
Young and old volunteers (n=12) were injected intra-dermally with 0.02ml of VZV 
antigen into the medial aspect of the proximal forearm.  Clinical score was recorded 
after 48-72 hours after injection and a 5mm punch biopsy was taken of the site after 
7 days.  The clinical score is plotted against the mean proportion of Foxp3-
expressing CD4+ T cells found in the skin at the peak of the cellular response (day 7) 
for each individual. There is an inverse correlation between the proportion of 
CD4+Foxp3+ cells present at the peak of the cellular response and the clinical score 
(linear regression analysis p=<0.0001). 
 
Therefore the CD4+Foxp3+ population identified in the skin during the DTH 
response to VZV skin test are phenotypically and functionally in keeping with 
T regulatory cells.  Next we wanted to investigate whether this population 
displayed specificity for VZV antigen. 
 
5.6 Identification of VZV-specific T regulatory cells in the skin after VZV 
antigen injection  
 
To determine whether there were VZV-specific T regulatory cells present, we 
looked to identify cells that positively stained for the HLA-DRB1*1501 
restricted IE63 tetramer in the CD4+Foxp3+ population.  To do this we raised 
skin suction blisters 7 days after cutaneous VZV antigen injection in young 
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volunteers known to be positive for HLA-DRB1*1501.  Tetramer positive cells 
could be identified in the CD4+Foxp3+ T cell population.  In most cases, 0-5% 
of cells, in both the CD4+ and CD4+Foxp3+ populations, were tetramer positive 
i.e. VZV-specific (Figure 5.9).  This similarity in proportion may hint at the 
populations arising in parallel during the DTH response as was seen in skin 
biopsies taken from young volunteers after VZV skin test (Figure 4.7).  
 
A B 
 
Figure 5.9 Identification of VZV specific (tetramer+) T regulatory cells at site of 
cutaneous DTH response 
 
Skin suction blisters were raised 7 days after cutaneous VZV antigen injection in 
young volunteers (n=13) known to be HLA-DRB1*1501 positive.  Blister cells were 
isolated and stained with HLA-DRB1*1501 restricted IE63 tetramer and for Foxp3 
expression. Samples were analyzed by flow cytometry. (A) Representative dot plot 
shows gating strategy to identify tetramer positive cells in both total CD4+ and 
CD4+Foxp3+ T cell populations. (B) Graph shows cumulative data and the mean 
value for each population. Each symbol represents one individual. The percentage of 
tetramer positive T cells is similar in both the total CD4+ and CD4+Foxp3+ T cell 
populations (p=0.6 Wilcoxon paired test). 
 
 
To characterise the phenotype of these CD4+Foxp3+tetramer+ T cells we 
compared the expression of CD25, CD127 and CD39 on the tetramer+Foxp3+ 
population with the tetramer+Foxp3- and the tetramer-Foxp3+/- populations 
(Figure 5.10A).  Within the Foxp3+ populations the majority of cells, both 
positive and negative for tetramer expressed high levels of CD25 and CD39 
typical of T regulatory cells or an activated state.  This was also true of the 
tetramer+Foxp3-Tcells, consistent with memory VZV-specific cells that we 
would expect to be activated.  This is in contrast to the tetramer-Foxp3-T cells 
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that may be neither activated, due to a lack of VZV specificity, nor T 
regulatory in nature.  Within the Foxp3+ population, more tetramer negative 
cells had a low expression of CD127 than did the tetramer positive population, 
suggesting a predominantly T regulatory phenotype in the former population 
but a combination of T regulatory and activated cells in the latter.  Some of the 
activated tetramer+Foxp3+ cells may be in a state of transition from a VZV-
specific effector T cell to a VZV-specific regulatory T cells.  
 
Looking at the combined expression of CD25 and CD127 in Foxp3 expressing 
CD4+ cells in both the tetramer + and - populations, we found that the majority 
of Foxp3+ cells within the tetramer negative population are CD25hiCD127lo 
rather than CD25hiCD127hi, suggestive of a T regulatory phenotype.  In the 
tetramer positive population, there is again a predominance of CD25hiCD127lo 
cells (~60%) consistent with the presence of a VZV-specific T regulatory cells 
but also a relevant proportion of CD25hiCD127hi cells again pointing to a 
population of either activated T cells or those that may be in transition to an 
iTreg  phenotype (Figure 5.7 D).    
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Figure 5.10 Phenotype of CD4+Foxp3+tetramer+ T cells at site of cutaneous DTH 
response  
 
Tetramer positive and negative, Foxp3+ and Foxp3-, CD4+ T cell populations were 
further analyzed for their expression of CD25, CD127 and CD39 (n=5-6). Graphs 
show cumulative data and the mean value for each subset.  Each symbol represents 
one individual. (A) The majority of Foxp3+ T cells in both the tetramer positive and 
negative populations express CD25 and CD39.  The majority of Foxp3+ tetramer 
negative T cells also are CD127lo whilst there is a more mixed population in the 
Foxp3+ tetramer positive population. (B) The majority of CD4+Foxp3+tetramer- T cells 
are CD25hiCD127lo in keeping with a Treg phenotype (right panel).  The majority of 
CD4+Foxp3+tetramer+ cells are also CD25hiCD127lo (left panel).  However, a relevant 
population that is CD25+CD127hi is also present. 
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5.7 Discussion 
 
We used a skin suction blister technique to allow further characterisation of 
the cellular response at the site of VZV antigen injection shown in chapter 4.  
We found that approximately 5% of CD4+ T cells in the skin after VZV antigen 
injection were VZV specific identified by cytokine secretion compared to 
approximately 3% identified by class II tetramer.  However, it is difficult to 
accurately determine the exact proportion of VZV specific cells at the site of 
the DTH response.  The proportion of cytokine producing T cells is likely to be 
an underestimate as some of the specific cells recovered from the injected 
skin site may be refractory to further activation in vitro while others may not 
have the capacity to secrete IL-2 or IFN-γ or be inhibited from doing so by 
Tregs.  Detection by tetramer is also likely to underestimate the true number 
as it will not detect VZV specific CD4+ T cells of different specificities that are 
also present within the skin after challenge.  Despite this, it can be seen that a 
significant proportion of the infiltrating cells are antigen specific.   
 
Production of IL-2 and IFN-γ by VZV specific T cells is in keeping with a 
combination of central memory and effector cells, confirmed by studying 
surface markers of differentiation.  However it should be noted that in both 
VZV-specific populations regardless of whether they secrete IFN-γ or IL-2, the 
predominant population is consistent with a central memory phenotype.  As 
within peripheral blood, the vast majority of VZV-specific cells are not highly 
differentiated (CD27+CD28+) although there is a slightly higher proportion of 
more differentiated cells (CD27-CD28+) in the skin (7.7% vs 16.3% IFN-γ+ and 
7.0% vs 9.9% IL-2+ of blood and blister cells respectively).  This is perhaps in 
keeping with the larger effector memory population seen in the skin compared 
to the blood (approximately 20% vs. 10% respectively) and may reflect more 
frequent involvement of this population in controlling clinically silent 
reactivations of VZV as it travels down peripheral nerves into the skin.  
Similarly herpes simplex virus 1 (HSV-1) specific T cells isolated from 
trigeminal ganglia are also more highly differentiated than those in peripheral 
blood (Verjans, Hintzen et al. 2007).  Differentiation was studied on cytokine 
producing VZV-specific T cells rather than those isolated by class II tetramer 
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as the former was a larger population and so more suitable for analysis of 
subpopulations.  
 
Using our blister technique to isolate leukocytes from the site of VZV antigen 
challenge in combination with a class II tetramer we were able to confirm that 
there is proliferation of VZV-specific cells in the skin, as suggested by 
histology (Figure 4.5).  Approximately 45% of tetramer positive cells were 
proliferating on day 7, as well as 20% of tetramer negative T cells.  This latter 
is suggestive of proliferation of CD4+ T cells responding to other VZV 
peptides.  Therefore while some antigen-specific T cells are recruited from the 
circulation, proliferation of VZV-specific T cells at the site of VZV challenge 
also contributes to the accumulation of VZV-specific cells.  Among these 
accumulating cells are some CD4+Foxp3+ cells.  By histology we identified 
that approximately 10% of the total number of CD4+ T cells/ PV infiltrate were 
Foxp3+ at day 7 after VZV injection although by our suction blister technique a 
mean of 16% were Foxp3+.  This difference may reflect a higher proportion of 
Foxp3+ T cells outside the immediate PV infiltrates examined by histology, 
e.g. around hair follicles (Clark and Kupper 2007) and provide a more 
accurate representation of the total skin area involved in the response.  The 
proportion of CD4+Foxp3+ T cells in the skin after VZV injection was 
significantly higher than in peripheral blood from the same individual.  This 
reflects the local accumulation of these cells in part due to local proliferation 
as shown by histology (Figure 4.8) as well as new transient expression of 
Foxp3 in activated T cells and possibly generation of iTregs from the effector 
T cells.   
 
We were able to show that CD4+Foxp3+ T cells in the skin isolated from 
suction blister typically expressed high levels of CD25, CD39 and low levels of 
CD127, in keeping with a Treg phenotype.  CD4+Foxp3+ T cells produced 
negligible IL-2, IFN-γ and TNF-α compared to CD4+Foxp3- T cells.  Nor did 
they secrete IL-10, an immune suppressive cytokine typically produced by 
Tregs in the intestinal mucosa (Maynard, Harrington et al. 2007; Rubtsov, 
Rasmussen et al. 2008).  The immune suppressive nature of the CD4+Foxp3+ 
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cells is indirectly conferred by the inverse correlation between the proportion 
of these cells and the clinical response to VZV antigen.  Therefore in keeping 
with previous work studying the response to the Mantoux test, CD4+Foxp3+ T 
cells that accumulate at the site of a DTH response to VZV are phenotypically 
and functionally suggestive of Tregs (Vukmanovic-Stejic, Agius et al. 2008) 
and most likely function to regulate the effector T cell response.  Using the 
class II tetramer we were also able to show that approximately 3% of both the 
total CD4+ and CD4+Foxp3+ populations were specific for VZV supporting the 
hypothesis that they accumulate in parallel. Phenotype analysis of the 
tetramer specific CD4+Foxp3+ T cells showed that the majority were in 
keeping with Tregs although some would be compatible with either activated 
CD4+ T cells which transiently express Foxp3 and high levels of both CD25 
and CD127 as well as cells which may be in a state of transition from a T 
effector to a Treg cell with a varying level of CD127 expression.   
 
Generation of Tregs from memory T cells during an immune response has 
been proposed as a mechanism for ensuring adequate regulation of the 
immune response (Akbar, Vukmanovic-Stejic et al. 2007).  It also provides an 
explanation for how Tregs may be maintained over the lifetime of an individual 
given that the number of naïve nTregs emigrating from the thymus declines 
with age (Booth, McQuaid et al. 2010) and that Tregs are unlikely to be a 
long-lived population.  Tregs are a highly proliferative population but probably 
with limited replicative capacity due to extensive telomere erosion and poor 
induction of telomerase compared to total CD4 T cells (Vukmanovic-Stejic, 
Zhang et al. 2006).  Furthermore it has been shown that Tregs express lower 
levels of the antiapoptotic molecule Bcl-2 rendering them susceptible to 
apoptosis (Vukmanovic-Stejic, Zhang et al. 2006).  Microarray analysis of 
RNA has also shown that gene expression profiles seen in CD45RO+ Tregs 
(i.e. activated Tregs) more closely resemble those of naïve and memory T 
conventional cells than naïve nTregs, indicating that from a genomic 
perspective, converted conventional T cells may make up a large proportion 
of the memory Treg pool (Booth, McQuaid et al. 2010).  Our data above 
shows that VZV-specific Tregs and effector T cells share antigen specificity 
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and arise in parallel at the site of antigen challenge supporting the hypothesis 
that iTregs may be derived from memory effector cells during an immune 
response.  If this were the case it is feasible that clinically silent reactivations 
of VZV in dorsal root ganglia migrating down peripheral nerves would 
generate new population of Tregs with each episode which may alter the 
balance of these two populations in favour of Tregs such that they are able to 
suppress the effector response allowing a clinical episode of herpes zoster to 
occur. Alternatively Tregs and naïve T cells may be generated with the same 
antigen specificity for non-self proteins within the thymus and become 
activated in tandem during an immune response. 
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Chapter 6:  Summary and future directions  	  
The aim of this study was to characterise the effects of ageing on the immune 
system in the skin in healthy old individuals. To do this we used the delayed 
type hypersensitivity response as a model for a memory T cell response.  Our 
antigen of interest was VZV.  Practically all adults in the UK acquire immunity 
to VZV through infection in childhood when it causes chickenpox. VZV-CMI 
declines with increasing age and is associated with an increased risk of VZV 
reactivation.  VZV reactivation may clinically present with shingles.   
 
To recruit elderly volunteers into our study we used a modified version of the 
SENIEUR protocol (Ligthart, Corberand et al. 1984) with a view to exclude 
significant co-morbidity and pharmacological interference but select a 
representative rather than exceptional group of old individuals.  Study of a 
similarly ‘almost healthy’ elderly population has shown significant differences 
in immune function compared to young individuals, not seen in the healthy old 
(Mysliwska, Bryl et al. 1999).  We performed both skin biopsies and suction 
blisters to study the immune response to VZV antigen.  Histological analysis 
of skin sections allowed us to identify the nature and kinetics of the cellular 
infiltrate while cells isolated from suction blisters allowed us to determine T 
cell specificity, function and phenotype.   
 
We show that elderly individuals injected with VZV antigen have a weaker 
clinical response assessed by erythema, palpability and diameter of 
induration.  This is despite similar numbers of circulating VZV specific CD4+ T 
cells.  There are however fewer circulating IFN-γ+CD4+ T in the elderly.  The 
cellular DTH response in the skin is defective in elderly individuals 
demonstrated by a lack of T cell accumulation at the site of antigen challenge.  
 
It is known that in response to trauma-induced DAMPs and pathogen induced 
PAMPs there is activation of PRRs as well as other receptors on cells of the 
innate immune system (Matzinger 2002; Medzhitov and Janeway 2002).  
Downstream signalling results in the production of pro-inflammatory cytokines 
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and chemokines, which are important for initiating an inflammatory response 
(Blackwell and Christman 1997).  One element of this is activation of dermal 
endothelium to express adhesion molecules required for the recruitment of 
circulating memory T cells and other leukocytes. Recent evidence suggests 
that, like innate immune cells, tissue resident memory T cells may also 
perform an ‘alarm function’ after antigen recognition and through the secretion 
of pro-inflammatory cytokines, induce the expression of chemokines to recruit 
circulating memory T cells (Strutt, McKinstry et al. 2010; Schenkel, Fraser et 
al. 2013).  The early recruitment of T cells from the circulation is not antigen 
specific (Ghani, Feuerer et al. 2009) but is vital for subsequent T cell 
accumulation (Hwang, Yamanouchi et al. 2004).  It is thought that this initial 
wave of recruitment will include some antigen specific T cells, which undergo 
activation and proliferation in the skin.  These activated antigen-specific cells 
would then provide an additional source of pro-inflammatory cytokines such 
as TNF-α and IFN-γ to further enhance endothelial activation such that there 
is larger scale recruitment of memory T cells.  Recruited DCs would provide a 
larger pool of APCs to present antigen to the increasing numbers of antigen 
specific T cells (McLachlan, Catron et al. 2009).  Tregs accumulate alongside 
effector T cells and provide a means of regulating the response (Vukmanovic-
Stejic, Agius et al. 2008; McLachlan, Catron et al. 2009)  
 
We propose that there is a population of VZV-specific T cells resident in 
normal skin and that these are involved in the generation of an antigen 
specific memory response.  There may be fewer functioning VZV specific T 
cells in the skin of elderly individuals compared to young individuals, 
alongside an increased proportion of Tregs that results in an impaired 
memory T cell response. We suggest that the innate immune response is 
intact demonstrated by similar expression of E-selectin on dermal 
endothelium and recruitment of neutrophils in young and old individuals 6 
hours after injection of either VZV antigen or normal saline.  Evidence for an 
early antigen specific defect is seen at 6 hours when there is an increase in 
the number of CD11c+ DCs only in young individuals and only after VZV 
antigen injection.  We hypothesise that with fewer VZV antigen specific cells 
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available to or able to undergo activation in the skin of the elderly there is 
lesser production of chemokines to attract circulating DCs and pro-
inflammatory cytokines such as IFN-γ to enhance endothelial activation.  The 
failure to increase E-selectin expression beyond 6 hours in the old individuals 
would be in keeping with this.  A cycle is therefore set up whereby VZV 
specific T cells in the skin do not adequately enhance activation of dermal 
endothelium nor produce chemokines needed to recruit DCs and T cells from 
the circulation to amplify the memory response.  Recruitment of macrophages 
may be similarly impaired.  
 
The number of functioning VZV specific T cells in the elderly may be reduced 
as a consequence of functional exhaustion in response to repeated subclinical 
reactivation of VZV along peripheral nerves.  Alternatively VZV specific cells 
in the skin of the elderly may come under increased suppression from the 
higher proportion of Tregs present.  In support of this hypothesis we showed 
that a small subset of elderly people who have clinical responses resembling 
those seen in the young, also have similar proportions of CD4+Foxp3+ T cells 
in normal skin.  Although we identified Tregs that shared antigen specificity 
with the effector T cell population in the young during the DTH response, it is 
more probable that the Tregs in normal skin act in a non-specific manner.  
These Tregs are perfectly placed to interfere with the earliest elements of T 
cell activation such as antigen presentation by dendritic cells.  Tregs are also 
able to inhibit macrophage function including TNF-α secretion (Taams, van 
Amelsfort et al. 2005; Tiemessen, Jagger et al. 2007).  We propose that it is 
the balance of Tregs versus Teffector cells that is important in determining the 
outcome of the DTH response (Lages, Suffia et al. 2008).  This balance could 
be altered by the shingles vaccine to increase either the pool of VZV specific 
T cells in the skin or those available for recruitment from the circulation with a 
subsequent increase in the cutaneous response to VZV antigen in the elderly 
(Takahashi, Kamiya et al. 2001).  It is not known why Tregs accumulate in the 
skin of old people but it may in part reflect a UV induced Treg population 
(Schwarz 2008) that has accumulated over years.  UV induced Tregs are able 
to alter the function of dendritic cells through secretion of IL-10 such that they 
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become ‘tolerogenic’ and induce the formation of further Tregs (Schwarz, 
Navid et al. 2011). 
 
In addition or as an alternative to the possibility of increased suppression of 
innate cell function by Tregs in the elderly, activation of VZV specific T cells in 
the skin may also be impaired secondary to age-related defects of innate cells 
involved in the response.  Defects in TLR function with ageing have been 
reported in both macrophages and dendritic cells (Shaw 2011)(van Duin, 
Allore et al. 2007; Agius, Lacy et al. 2009) and may contribute to a reduced 
level of early pro-inflammatory cytokine production in the elderly.  Age-related 
defects in macrophage polarization with suppression of both M1 (pro-
inflammatory) and M2 (anti-inflammatory) responses have also been reported 
(Mahbub, Deburghgraeve et al. 2012).  
 
An alternative hypothesis to the existence of a skin resident population of VZV 
specific cells that initiates the specific response is that antigen-specific T cells 
from the circulation are recruited non-specifically to the site of inflammation 
and then initiate the antigen specific response after encountering antigen. It 
has been proposed by other work (Ghani, Feuerer et al. 2009) that early 
danger signals trigger low-level, non-antigen specific infiltration of circulating T 
cells and other leucocytes.  Local antigen presented by resident or recruited 
APCs would initiate the activation of a few antigen-specific T cells within the 
infiltrate and act as ‘pioneering cells’ (Ghani, Feuerer et al. 2009).  These 
activated antigen-specific T cells could then produce pro-inflammatory 
mediators such as IFN-γ and TNF-α either directly or indirectly via 
macrophages to activate endothelium and stimulate chemokine-producing 
cells to promote recruitment of large numbers of T cells and other leukocytes.  
Antigen-specific T cells could undergo proliferation in the skin after activation.  
Under these circumstances, since there are fewer functioning VZV-specific 
cells in the circulation to be recruited into the skin in old individuals, there 
would be a diminished accumulation of T cells, as is shown in our results.  
These two hypotheses mentioned above are not mutually exclusive and we 
feel that it is likely that the reduced number of circulating VZV specific 
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CD4+IFNγ+ cells in the elderly compounds an earlier defect in the initial 
activation of VZV specific T cells in the skin resulting in reduced T cell 
accumulation.  
 
To investigate these hypotheses further it would be of interest to determine 
the number of VZV specific T cells isolated from normal skin in the old and 
young and their phenotype to identify a TRM resident-like population.  It would 
be important to assess the ability of these cells to secrete pro-inflammatory 
cytokines after in vitro stimulation with VZV lysate both in the presence and 
absence of the Tregs to exclude the possibility that VZV specific T cells 
present in normal skin may be intrinsically defective in the elderly.  Production 
of cytokines, chemokines and activation of pro-inflammatory or anti-
inflammatory pathways could be investigated by transcriptional analysis of the 
skin after VZV antigen injection.  
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